<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/358AC957-81B4-4AD3-8AEF-0D0CB8CA7024"><gtr:id>358AC957-81B4-4AD3-8AEF-0D0CB8CA7024</gtr:id><gtr:name>Zora Biosciences Oy</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/ACE08F7D-0E5C-4213-BF46-7C1A9DDD8B2C"><gtr:id>ACE08F7D-0E5C-4213-BF46-7C1A9DDD8B2C</gtr:id><gtr:name>Regional Government of Valencia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/856A7EAA-C834-4DBE-8764-98C315C40614"><gtr:id>856A7EAA-C834-4DBE-8764-98C315C40614</gtr:id><gtr:name>Mario Negri Institute for Pharmacological Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF304075-C803-45F8-8F68-0CC2B0BE0135"><gtr:id>EF304075-C803-45F8-8F68-0CC2B0BE0135</gtr:id><gtr:name>Osaka University</gtr:name><gtr:address><gtr:line1>1-1 Yamadaoka Suita</gtr:line1><gtr:postCode>565 0871</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A15DEEDB-5ADC-4395-A1FD-D7C81690EF3A"><gtr:id>A15DEEDB-5ADC-4395-A1FD-D7C81690EF3A</gtr:id><gtr:name>Graz University</gtr:name><gtr:address><gtr:line1>Graz University</gtr:line1><gtr:line2>Rechbauerstrasse 12</gtr:line2><gtr:postCode>A-8010</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/354610BC-CCBE-43F3-8DD6-BB675FC6E62B"><gtr:id>354610BC-CCBE-43F3-8DD6-BB675FC6E62B</gtr:id><gtr:name>Chiba University</gtr:name><gtr:address><gtr:line1>Chiba University</gtr:line1><gtr:line2>1-33, Yayoi-cho</gtr:line2><gtr:line4>Inage-Ku</gtr:line4><gtr:line5>Chiba-shi</gtr:line5><gtr:postCode>263-8522</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F5AB6AF3-9BC1-4877-9784-74C8145C7032"><gtr:id>F5AB6AF3-9BC1-4877-9784-74C8145C7032</gtr:id><gtr:name>The Wenner-Gren Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/75D71200-19AA-45B0-87C7-4A777DF9725D"><gtr:id>75D71200-19AA-45B0-87C7-4A777DF9725D</gtr:id><gtr:name>Spanish Ministry of Health and Consumer Affairs</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B5C98D91-0942-43B7-862C-53BE745F141F"><gtr:id>B5C98D91-0942-43B7-862C-53BE745F141F</gtr:id><gtr:name>University of Santiago de Compostela</gtr:name><gtr:address><gtr:line1>Colexio de San Xerome</gtr:line1><gtr:line2>Praza do Obradoiro, s/n</gtr:line2><gtr:line3>15782 Santiago de Compostela</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7D871ECD-66F3-4DAC-A0DE-8D6359F0842F"><gtr:id>7D871ECD-66F3-4DAC-A0DE-8D6359F0842F</gtr:id><gtr:name>Toho University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1E06C677-C6F2-4B03-A434-0CB4CAD49D81"><gtr:id>1E06C677-C6F2-4B03-A434-0CB4CAD49D81</gtr:id><gtr:name>Technical Research Centre of Finland (VTT)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6DCA7B7A-0111-4A7C-95CC-DEAD58B89132"><gtr:id>6DCA7B7A-0111-4A7C-95CC-DEAD58B89132</gtr:id><gtr:name>University of Stockholm</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514"><gtr:id>926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514</gtr:id><gtr:name>German Cancer Research Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F5569A12-0A1B-4474-B608-84BB0C44B3A7"><gtr:id>F5569A12-0A1B-4474-B608-84BB0C44B3A7</gtr:id><gtr:name>University of Minnesota</gtr:name><gtr:address><gtr:line1>127 Vincent Hall</gtr:line1><gtr:line2>206 Church St. S.E</gtr:line2><gtr:line4>Minneapolis</gtr:line4><gtr:line5>MN 55455</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/358AC957-81B4-4AD3-8AEF-0D0CB8CA7024"><gtr:id>358AC957-81B4-4AD3-8AEF-0D0CB8CA7024</gtr:id><gtr:name>Zora Biosciences Oy</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ACE08F7D-0E5C-4213-BF46-7C1A9DDD8B2C"><gtr:id>ACE08F7D-0E5C-4213-BF46-7C1A9DDD8B2C</gtr:id><gtr:name>Regional Government of Valencia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/856A7EAA-C834-4DBE-8764-98C315C40614"><gtr:id>856A7EAA-C834-4DBE-8764-98C315C40614</gtr:id><gtr:name>Mario Negri Institute for Pharmacological Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF304075-C803-45F8-8F68-0CC2B0BE0135"><gtr:id>EF304075-C803-45F8-8F68-0CC2B0BE0135</gtr:id><gtr:name>Osaka University</gtr:name><gtr:address><gtr:line1>1-1 Yamadaoka Suita</gtr:line1><gtr:postCode>565 0871</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A15DEEDB-5ADC-4395-A1FD-D7C81690EF3A"><gtr:id>A15DEEDB-5ADC-4395-A1FD-D7C81690EF3A</gtr:id><gtr:name>Graz University</gtr:name><gtr:address><gtr:line1>Graz University</gtr:line1><gtr:line2>Rechbauerstrasse 12</gtr:line2><gtr:postCode>A-8010</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/354610BC-CCBE-43F3-8DD6-BB675FC6E62B"><gtr:id>354610BC-CCBE-43F3-8DD6-BB675FC6E62B</gtr:id><gtr:name>Chiba University</gtr:name><gtr:address><gtr:line1>Chiba University</gtr:line1><gtr:line2>1-33, Yayoi-cho</gtr:line2><gtr:line4>Inage-Ku</gtr:line4><gtr:line5>Chiba-shi</gtr:line5><gtr:postCode>263-8522</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5AB6AF3-9BC1-4877-9784-74C8145C7032"><gtr:id>F5AB6AF3-9BC1-4877-9784-74C8145C7032</gtr:id><gtr:name>The Wenner-Gren Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/75D71200-19AA-45B0-87C7-4A777DF9725D"><gtr:id>75D71200-19AA-45B0-87C7-4A777DF9725D</gtr:id><gtr:name>Spanish Ministry of Health and Consumer Affairs</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B5C98D91-0942-43B7-862C-53BE745F141F"><gtr:id>B5C98D91-0942-43B7-862C-53BE745F141F</gtr:id><gtr:name>University of Santiago de Compostela</gtr:name><gtr:address><gtr:line1>Colexio de San Xerome</gtr:line1><gtr:line2>Praza do Obradoiro, s/n</gtr:line2><gtr:line3>15782 Santiago de Compostela</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7D871ECD-66F3-4DAC-A0DE-8D6359F0842F"><gtr:id>7D871ECD-66F3-4DAC-A0DE-8D6359F0842F</gtr:id><gtr:name>Toho University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1E06C677-C6F2-4B03-A434-0CB4CAD49D81"><gtr:id>1E06C677-C6F2-4B03-A434-0CB4CAD49D81</gtr:id><gtr:name>Technical Research Centre of Finland (VTT)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6DCA7B7A-0111-4A7C-95CC-DEAD58B89132"><gtr:id>6DCA7B7A-0111-4A7C-95CC-DEAD58B89132</gtr:id><gtr:name>University of Stockholm</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514"><gtr:id>926FCE3B-DFAB-4FE7-9BF8-7372B5AA9514</gtr:id><gtr:name>German Cancer Research Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5569A12-0A1B-4474-B608-84BB0C44B3A7"><gtr:id>F5569A12-0A1B-4474-B608-84BB0C44B3A7</gtr:id><gtr:name>University of Minnesota</gtr:name><gtr:address><gtr:line1>127 Vincent Hall</gtr:line1><gtr:line2>206 Church St. S.E</gtr:line2><gtr:line4>Minneapolis</gtr:line4><gtr:line5>MN 55455</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/521E032C-C065-41B2-9CEA-9A06C8BC5312"><gtr:id>521E032C-C065-41B2-9CEA-9A06C8BC5312</gtr:id><gtr:firstName>Antonio</gtr:firstName><gtr:surname>Vidal-Puig</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12012%2F2"><gtr:id>6F57C436-327C-4FCD-9C2F-434F52809F58</gtr:id><gtr:title>Lipotoxicity and obesity-associated metabolic complications</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12012/2</gtr:grantReference><gtr:abstractText>This programme focuses on the role of the fat tissue mediating the link between obesity, diabetes and cardiovascular problems through a mechanism involving toxic effects of fat. Specifically we aim to: a) establish mechanisms controlling how the adipose tissue grows to learn how to prevent the metabolic problems typically associated with obesity such as diabetes and heart attacks; b) to define whether targeting the brown adipose tissue, a type of fat that makes heat may prevent or reverse obesity associated complications; and c) identify diagnostic biomarkers and treatments based on patterns of lipids in mice, for subsequent confirmation in humans. These objectives will be addressed through a multidisciplinary approach that will make use of mice, state of the art in vivo and in vitro characterisation, and advanced computational systems to integrate the information.</gtr:abstractText><gtr:technicalSummary>This programme focuses on the roles of adipose tissue expandability and function in mediating the link between obesity and associated metabolic complications through lipotoxic mechanisms. Specifically we aim to: a) establish mechanisms controlling adipose tissue plasticity and expansion as a strategy to prevent the development of obesity-associated metabolic complications; b) define the anti-lipotoxic effects of mitochondrial oxidation through strategies that promote the differentiation and activation of brown fat (BAT); and c) identify candidate diagnostic biomarkers and therapeutic approaches based on patterns of lipid species associated with lipotoxicity in mice, for subsequent validation in human translational studies. These objectives will be addressed through a multidisciplinary approach that will make extensive use of genetically modified murine models, state of the art in vivo and in vitro phenotyping, and systems approaches based on transcriptomic and lipidomic technologies integrated by multiple bioinformatics platforms.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1612000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>Use of Social Media
TVPLAB TWITTER
https://twitter.com/tvplab?lang=en-gb</gtr:description><gtr:id>D5364240-1F55-421C-AAB9-F5395691EBF9</gtr:id><gtr:impact>Creative tool to communicate our science to public</gtr:impact><gtr:outcomeId>56d2d8f17aead1.22784339</gtr:outcomeId><gtr:title>TVPLAB twitter</gtr:title><gtr:type>Creative Writing</gtr:type><gtr:url>https://twitter.com/tvplab?lang=en-gb</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>tvp.mrl.ims.cam.ac.uk/</gtr:description><gtr:id>36C297BF-2C63-4AFC-AC9A-D9553B5F4665</gtr:id><gtr:impact>Much broader reach attracting more visitors</gtr:impact><gtr:outcomeId>5455075cd45308.82073692</gtr:outcomeId><gtr:title>Development of new webb for the TVP lab</gtr:title><gtr:type>Creative Writing</gtr:type><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Santiago de Compostela</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Physiology</gtr:department><gtr:description>Thermogenesis</gtr:description><gtr:id>756B273B-D9F1-45EB-B61E-A0EF66AE6B50</gtr:id><gtr:impact>Whittle, A.J., S. Carobbio, L. Martins, M. Slawik, E. Hondares, (11 authors),A. Vidal-Puig, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell, 2012. 149(4): p. 871-85.

Lopez, M., R. Lage, A.K. Saha, D. Perez-Tilve, M.J. Vazquez, (17 authors), A. Vidal-Puig, Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab, 2008. 7(5): p. 389-99.

Lopez, M., L. Varela, M.J. Vazquez, S. Rodriguez-Cuenca, C.R. Gonzalez,(16 authors) and A. Vidal-Puig, Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med, 2010. 16(9): p. 1001-8.

 Lee EY, Sakurai K, Zhang X, Toda C, Tanaka T, Jiang M, Shirasawa T, Tachibana K, Yokote K, Vidal-Puig A, Minokoshi Y, Miki T. Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet. Sci Rep. 2015 Nov 30;5:17565. doi: 10.1038/srep17565.

4. Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A*, Bujo H*. Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nat Commun. 2015 Nov 20;6:8951. doi: 10.1038/ncomms9951.* Corresponding Author

Schreiber R, Hofer P, Taschler U, Voshol PJ, Rechberger GN, Kotzbeck P, Jaeger D, Preiss-Landl K, Lord CC, Brown JM, Haemmerle G, Zimmermann R, Vidal-Puig A, Zechner R Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity. Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13850-5. doi: 10.1073/pnas.1516004112. Epub 2015 Oct 27

 Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>ivUFBKbUfAu-1</gtr:outcomeId><gtr:partnerContribution>Specific Thermogenic studies covering CNS, BAT and electrophysiology</gtr:partnerContribution><gtr:piContribution>Murine generation and Phenotyping</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wenner-Gren Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Phsyiology</gtr:department><gtr:description>Brown fat</gtr:description><gtr:id>729A7C0F-AE33-4188-8939-D4581BA15603</gtr:id><gtr:impact>Virtue S, Feldmann H, Christian M, Tan CY, Masoodi M, Dale M, Lelliott C, Burling K, Campbell M, Eguchi N, Voshol P, Sethi JK, Parker M, Urade Y, Griffin JL, Cannon B, Vidal-Puig A. A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes 61(12):3139-47 (2012).Virtue S, F.H., Christian M, Tan CY, Masoodi M, Dale M, et al (10 authors) Vidal-Puig A. Diabetes in press (2012), 
Virtue, S., M. Christian, C. Tan, M. Masoodi, M. Dale, ( 10 authors) A. Vidal-Puig, A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes (in press) 2012.

Whittle, A.J., S. Carobbio, L. Martins, M. Slawik, E. Hondares, (11 authors),A. Vidal-Puig, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell, 2012. 149(4): p. 871-85.</gtr:impact><gtr:outcomeId>rGM9RiYT3WW-1</gtr:outcomeId><gtr:partnerContribution>Knowledge and technology</gtr:partnerContribution><gtr:piContribution>We have developed a new area of research focused on BAT</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Molecular mechanisms of mitochondrial biogenesis</gtr:description><gtr:id>2594C0E3-06B2-42EF-BBD7-AC1F7EF6EB29</gtr:id><gtr:impact>Integration in FP7 Etherpath grant</gtr:impact><gtr:outcomeId>9D872B81BCD-2</gtr:outcomeId><gtr:partnerContribution>Providing animal models generated by AZaccess to lipidomic platforms</gtr:partnerContribution><gtr:piContribution>Provided biological samples for platform development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technical Research Centre of Finland (VTT)</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:department>Matej Oresic VTT</gtr:department><gtr:description>Lipidomic technology</gtr:description><gtr:id>00CD4BCC-8286-4B62-B2B5-A7E1E69DD817</gtr:id><gtr:impact>1.Medina-Gomez G, Yetukuri L, Velagapudi V, Campbell M, Blount M, Jimenez-Linan M, Ros M, Oresic M, Vidal-Puig A. Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome. Dis Model Mech. 2009 Nov-Dec;2(11-12):582-92. Epub 2009 Oct 19. PMID: 19841237 2.Tang J, Tan CY, Oresic M, Vidal-Puig A.Integrating post-genomic approaches as a strategy to advance our understanding of health and disease.Genome Med. 2009 Mar 30;1(3):35.PMID: 19341506 3.Oresic M, H&amp;auml;nninen VA, Vidal-Puig A.Lipidomics: a new window to biomedical frontiers. Trends Biotechnol. 2008 Dec;26(12):647-52. Epub 2008 Oct 23. PMID: 18951641 4.Yetukuri L, Ekroos K, Vidal-Puig A, Oresic M.Informatics and computational strategies for the study of lipids. Mol Biosyst. 2008 Feb;4(2):121-7. PMID: 18213405 5.Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, Jimenez-Linan M, Blount M, Yeo GS, Lopez M, Sepp&amp;auml;nen-Laakso T, Ashcroft FM, Oresic M, Vidal-Puig A.PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.PLoS Genet. 2007 Apr 27;3(4):e64. PMID: 17465682 6.Yetukuri L, Katajamaa M, Medina-Gomez G, Sepp&amp;auml;nen-Laakso T, Vidal-Puig A, Oresic M.Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis.BMC Syst Biol. 2007 Feb 15;1:12. PMID: 17408502 7.Lelliott CJ, Medina-Gomez G, Petrovic N, Kis A, Feldmann HM, Bjursell M, Parker N, Curtis K, Campbell M, Hu P, Zhang D, Litwin SE, Zaha VG, Fountain KT, Boudina S, Jimenez-Linan M, Blount M, Lopez M, Meirhaeghe A, Bohlooly-Y M, Storlien L, Str&amp;ouml;mstedt M, Snaith M, Oresic M, Abel ED, Cannon B, Vidal-Puig A.Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance.PLoS Biol. 2006 Nov;4(11):e369.PMID: 17090215 8.Oresic M, Vidal-Puig A, H&amp;auml;nninen V. Metabolomic approaches to phenotype characterization and applications to complex diseases.Expert Rev Mol Diagn. 2006 Jul;6(4):575-85. Review. PMID: 16824031 

15. Virtue S, F.H., Christian M, Tan CY, Masoodi M, Dale M, et al (10 authors) Vidal-Puig A. Diabetes in press (2012), A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes, (2012.)

Virtue, S., M. Christian, C. Tan, M. Masoodi, M. Dale, C. ( 10 authors) A. Vidal-Puig, A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes 2012.

Griffin, J.L. and A. Vidal-Puig, Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding? Physiol Genomics, 2008. 34(1): p. 1-5.

Pietilainen, K.H., T. Rog, T. Seppanen-Laakso, S. Virtue, P. Gopalacharyulu, J.(16 authors), A. Vidal-Puig, and M. Oresic, Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol, 2011. 9(6): p. e1000623.
19. Prieur, X., C.Y. Mok, V.R. Velagapudi, V. Nunez, L. Fuentes, D. (9 authors), A. Vidal-Puig, Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes, 2011. 60(3): p. 797-809.
20. Kilpelainen, T.O., M.C. Zillikens, A. Stancakova, F.M. Finucane, J.S. Ried, C. Langenberg, (65 authors) A. Vidal-Puig, (40 authors) R.J. Loos, Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet, 2011. 43(8): p. 753-60.
21. Medina-Gomez, G., L. Yetukuri, V. Velagapudi, M. Campbell, M. Blount,et al (3 authors), A. Vidal-Puig, Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome. Dis Model Mech, 2009. 2(11-12): p. 582-92.
22. Vivas, Y., C. Martinez-Garcia, A. Izquierdo, F. Garcia-Garcia, S. Callejas, (4 authors), A. Vidal-Puig, and G. Medina-Gomez, Early peroxisome proliferator-activated receptor gamma regulated genes involved in expansion of pancreatic beta cell mass. BMC Med Genomics, 2012. 4: p. 86.
Virtue S, Feldmann H, Christian M, Tan CY, Masoodi M, Dale M, Lelliott C, Burling K, Campbell M, Eguchi N, Voshol P, Sethi JK, Parker M, Urade Y, Griffin JL, Cannon B, Vidal-Puig A. A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes 61(12):3139-47 (2012).

4. Carobbio S, Hagen RM, Lelliott CJ, Slawik M, Medina-Gomez G, Tan CY, Sicard A, Atherton HJ, Barbarroja N, Bjursell M, Bohlooly-Y M, Virtue S, Tuthill A, Lefai E, Laville M, Wu T, Considine RV, Vidal H, Langin D, Oresic M, Tinahones FJ, Fernandez-Real JM, Griffin JL, Sethi JK, L&amp;oacute;pez M, Vidal-Puig A. Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity. Diabetes 2013 Aug 6. [Epub ahead of print]

12. Virtue S, Masoodi M, Velagapudi V, Tan CY, Dale M, Suorti T, Slawik M, Blount M, Burling K, Campbell M, Eguchi N, Medina-Gomez G, Sethi JK, Ore?ic M, Urade Y, Griffin JL, Vidal-Puig A. Lipocalin Prostaglandin D Synthase and PPAR?2 Coordinate to Regulate Carbohydrate and Lipid Metabolism In Vivo. PLoS One 7(7):e39512. (2012)

Rodriguez-Cuenca S, Carobbio S, Velagapudi VR, Barbarroja N, Moreno-Navarrete JM, Tinahones FJ, Fernandez-Real JM, Oresic M, Vidal-Puig A. PPAR? DEPENDENT REGULATION OF LIPOLYTIC NODES AND METABOLIC FLEXIBILITY. Moll Cell Biol. 2012 Feb 6.</gtr:impact><gtr:outcomeId>CDC21732DE6-1</gtr:outcomeId><gtr:partnerContribution>Providing lipidomic analysis from biological samples.</gtr:partnerContribution><gtr:piContribution>provided intellectual framework, experimental design and biological samples.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technical Research Centre of Finland (VTT)</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:department>QBIX Group</gtr:department><gtr:description>Lipidomic analysis in the context of lipotoxicity</gtr:description><gtr:id>DCE22428-8989-4DA6-9F4F-CB6ED1D2D160</gtr:id><gtr:impact>Barbarroja N, Rodriguez-Cuenca S, Nygren H, Camargo A, Pirraco A, Relat J, Cuadrado I, Pellegrinelli V, Medina-Gomez G, Lopez-Pedrera C, Tinahones FJ, Symons JD, Summers SA, Oresic M, Vidal-Puig A.Increased dihydroceramide/ceramide ratio mediated by defective expression of degs1 impairs adipocyte differentiation and function.Diabetes. 2015 Apr;64(4):1180-92. doi: 10.2337/db14-0359. Epub 2014 Oct 28.
PMID: 25352638 Free Article



Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity.


Carobbio S, Hagen RM, Lelliott CJ, Slawik M, Medina-Gomez G, Tan CY, Sicard A, Atherton HJ, Barbarroja N, Bjursell M, Bohlooly-Y M, Virtue S, Tuthill A, Lefai E, Laville M, Wu T, Considine RV, Vidal H, Langin D, Oresic M, Tinahones FJ, Fernandez-Real JM, Griffin JL, Sethi JK, L&amp;oacute;pez M, Vidal-Puig A.Diabetes. 2013 Nov;62(11):3697-708. doi: 10.2337/db12-1748. Epub 2013 Aug 6.
PMID: 23919961 Free PMC Article



Virtue S, Masoodi M, Velagapudi V, Tan CY, Dale M, Suorti T, Slawik M, Blount M, Burling K, Campbell M, Eguchi N, Medina-Gomez G, Sethi JK, Ore?ic M, Urade Y, Griffin JL, Vidal-PuigLipocalin prostaglandin D synthase and PPAR?2 coordinate to regulate carbohydrate and lipid metabolism in vivo.A.PLoS One. 2012;7(7):e39512. doi: 10.1371/journal.pone.0039512. Epub 2012 Jul 5.
PMID: 22792179 Free PMC Article1. 

Prieur X, Mok CY, Velagapudi VR, N&amp;uacute;&amp;ntilde;ez V, Fuentes L, Montaner D, Ishikawa K, Camacho A, Barbarroja N, O'Rahilly S, Sethi J, Dopazo J, Oresic M, Ricote M, Vidal-Puig A. Differential Lipid Partitioning Between Adipocytes and Tissue Macrophages Modulates Macrophage Lipotoxicity and M2/M1 Polarization in Obese Mice. Diabetes Jan 24, 2011. 

 Pietil&amp;auml;inen KH, R&amp;oacute;g T, Sepp&amp;auml;nen-Laakso T, Virtue S, Gopalacharyulu P, Tang J, Rodriguez-Cuenca S, Maciejewski A, Naukkarinen J, Ruskeep&amp;auml;&amp;auml; AL, Niemel&amp;auml; PS, Yetukuri L, Tan CY, Velagapudi V, Castillo S, Nygren H, Hy&amp;ouml;tyl&amp;auml;inen T, Rissanen A, Kaprio J, Yki-J&amp;auml;rvinen H, Vattulainen I, Vidal-Puig A, Ore?ic M. Association of lipidome remodelling in the adipocyte membrane with acquired obesity in humans. PLoS Biol June 7, 2011. 1.Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance.

3. L&amp;oacute;pez M, Varela L, V&amp;aacute;zquez MJ, Rodr&amp;iacute;guez-Cuenca S, Gonz&amp;aacute;lez CR, Velagapudi VR, Morgan DA, Schoenmakers E, Agassandian K, Lage R, Mart&amp;iacute;nez de Morentin PB, Tovar S, Nogueiras R, Carling D, Lelliott C, Gallego R, Oresic M, Chatterjee K, Saha AK, Rahmouni K, Di&amp;eacute;guez C, Vidal-Puig A.Nat Med. 2010 Sep;16(9):1001-8. Epub 2010 Aug 29.
PMID: 20802499 [PubMed - indexed for MEDLINE]Related citations

Lagathu C, Christodoulides C, Tan CY, Virtue S, Laudes M, Campbell M, Ishikawa K, Ortega F, Tinahones FJ, Fern&amp;aacute;ndez-Real JM, Ore?ic M, Sethi JK, Vidal-Puig A.4.Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity. Int J Obes (Lond). 2010 Jun 1. PMID: 20514047 [PubMed - as supplied by publisher]

5.Medina-Gomez G, Yetukuri L, Velagapudi V, Campbell M, Blount M, Jimenez-Linan M, Ros M, Oresic M, Vidal-Puig A.
Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome.
Dis Model Mech. 2009 Nov-Dec;2(11-12):582-92. Epub 2009 Oct 19.
PMID: 19841237 [PubMed - indexed for MEDLINE]Free PMC ArticleFree text

Tang J, Tan CY, Oresic M, Vidal-Puig .Integrating post-genomic approaches as a strategy to advance our understanding of health and disease.
Genome Med. 2009 Mar 30;1(3):35.PMID: 19341506 [PubMed - in process]Free PMC ArticleFree text

Tang J, Tan CY, Oresic M, Vidal-Puig A.Lipidomics: a new window to biomedical frontiers.
Trends Biotechnol. 2008 Dec;26(12):647-52. Epub 2008 Oct 23.
PMID: 18951641 [PubMed - indexed for MEDLINE]


.

Yetukuri L, Ekroos K, Vidal-Puig A, Oresic M.8.Informatics and computational strategies for the study of lipids
Mol Biosyst. 2008 Feb;4(2):121-7. Epub 2007 Dec 18. Review.
PMID: 18213405 [PubMed - indexed for MEDLINE]
Related citations
9.PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.

Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, Jimenez-Linan M, Blount M, Yeo GS, Lopez M, Sepp&amp;auml;nen-Laakso T, Ashcroft FM, Oresic M, Vidal-Puig A.

PLoS Genet. 2007 Apr 27;3(4):e64.
PMID: 17465682 [PubMed - indexed for MEDLINE]Free PMC ArticleFree text
Related citations
10.Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis.

Yetukuri L, Katajamaa M, Medina-Gomez G, Sepp&amp;auml;nen-Laakso T, Vidal-Puig A, Oresic M.

BMC Syst Biol. 2007 Feb 15;1:12.
PMID: 17408502 [PubMed - indexed for MEDLINE]Free PMC ArticleFree text
Related citations
11.Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance.

Lelliott CJ, Medina-Gomez G, Petrovic N, Kis A, Feldmann HM, Bjursell M, Parker N, Curtis K, Campbell M, Hu P, Zhang D, Litwin SE, Zaha VG, Fountain KT, Boudina S, Jimenez-Linan M, Blount M, Lopez M, Meirhaeghe A, Bohlooly-Y M, Storlien L, Str&amp;ouml;mstedt M, Snaith M, Oresic M, Abel ED, Cannon B, Vidal-Puig A.

PLoS Biol. 2006 Nov;4(11):e369.
PMID: 17090215 [PubMed - indexed for MEDLINE]Free PMC ArticleFree text
Related citations
12.Metabolomic approaches to phenotype characterization and applications to complex diseases.

Oresic M, Vidal-Puig A, H&amp;auml;nninen V.

Expert Rev Mol Diagn. 2006 Jul;6(4):575-85. Review.
PMID: 16824031 [PubMed - indexed for MEDLINE]
Related citations
13.Pathways to the analysis of microarray data.

Curtis RK, Oresic M, Vidal-Puig A.

Trends Biotechnol. 2005 Aug;23(8):429-35. Review.
PMID: 15950303 [PubMed - indexed for MEDLINE]
Related citations
14.The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform.

15.Medina-Gomez G, Virtue S, Lelliott C, Boiani R, Campbell M, Christodoulides C, Perrin C, Jimenez-Linan M, Blount M, Dixon J, Zahn D, Thresher RR, Aparicio S, Carlton M, Colledge WH, Kettunen MI, Sepp&amp;auml;nen-Laakso T, Sethi JK, O'Rahilly S, Brindle K, Cinti S, Oresic M, Burcelin R, Vidal-Puig A.

Diabetes. 2005 Jun;54(6):1706-16.
PMID: 15919792 [PubMed - indexed for MEDLINE]Free Article
Related citations</gtr:impact><gtr:outcomeId>EWQ77GjDGSJ-1</gtr:outcomeId><gtr:partnerContribution>The lab of Prof Matej Oresic has performed lipidomic analysis in murine tissues from our genetically modified models. Our models have provided biological material for analytical platform development. Funding forthis experiments has been provided through collaborative FP6 Hepadip and FP7 Etherpath grants,</gtr:partnerContribution><gtr:piContribution>We have provided biological samples for lipidomic analysis and
th eintellectual background to justify this programme of research</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Toho University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Thermogenesis</gtr:description><gtr:id>C75CEE82-B572-4141-B806-228BB0A0C1C7</gtr:id><gtr:impact>Whittle, A.J., S. Carobbio, L. Martins, M. Slawik, E. Hondares, (11 authors),A. Vidal-Puig, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell, 2012. 149(4): p. 871-85.

Lopez, M., R. Lage, A.K. Saha, D. Perez-Tilve, M.J. Vazquez, (17 authors), A. Vidal-Puig, Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab, 2008. 7(5): p. 389-99.

Lopez, M., L. Varela, M.J. Vazquez, S. Rodriguez-Cuenca, C.R. Gonzalez,(16 authors) and A. Vidal-Puig, Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med, 2010. 16(9): p. 1001-8.

 Lee EY, Sakurai K, Zhang X, Toda C, Tanaka T, Jiang M, Shirasawa T, Tachibana K, Yokote K, Vidal-Puig A, Minokoshi Y, Miki T. Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet. Sci Rep. 2015 Nov 30;5:17565. doi: 10.1038/srep17565.

4. Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A*, Bujo H*. Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nat Commun. 2015 Nov 20;6:8951. doi: 10.1038/ncomms9951.* Corresponding Author

Schreiber R, Hofer P, Taschler U, Voshol PJ, Rechberger GN, Kotzbeck P, Jaeger D, Preiss-Landl K, Lord CC, Brown JM, Haemmerle G, Zimmermann R, Vidal-Puig A, Zechner R Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity. Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13850-5. doi: 10.1073/pnas.1516004112. Epub 2015 Oct 27

 Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>ivUFBKbUfAu-4</gtr:outcomeId><gtr:partnerContribution>Specific Thermogenic studies covering CNS, BAT and electrophysiology</gtr:partnerContribution><gtr:piContribution>Murine generation and Phenotyping</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Minnesota</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Integrative Biology and Physiology</gtr:department><gtr:description>Thermogenesis</gtr:description><gtr:id>4046A4B8-6460-48DE-88B1-AB30DF0AEFA8</gtr:id><gtr:impact>Whittle, A.J., S. Carobbio, L. Martins, M. Slawik, E. Hondares, (11 authors),A. Vidal-Puig, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell, 2012. 149(4): p. 871-85.

Lopez, M., R. Lage, A.K. Saha, D. Perez-Tilve, M.J. Vazquez, (17 authors), A. Vidal-Puig, Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab, 2008. 7(5): p. 389-99.

Lopez, M., L. Varela, M.J. Vazquez, S. Rodriguez-Cuenca, C.R. Gonzalez,(16 authors) and A. Vidal-Puig, Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med, 2010. 16(9): p. 1001-8.

 Lee EY, Sakurai K, Zhang X, Toda C, Tanaka T, Jiang M, Shirasawa T, Tachibana K, Yokote K, Vidal-Puig A, Minokoshi Y, Miki T. Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet. Sci Rep. 2015 Nov 30;5:17565. doi: 10.1038/srep17565.

4. Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A*, Bujo H*. Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nat Commun. 2015 Nov 20;6:8951. doi: 10.1038/ncomms9951.* Corresponding Author

Schreiber R, Hofer P, Taschler U, Voshol PJ, Rechberger GN, Kotzbeck P, Jaeger D, Preiss-Landl K, Lord CC, Brown JM, Haemmerle G, Zimmermann R, Vidal-Puig A, Zechner R Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity. Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13850-5. doi: 10.1073/pnas.1516004112. Epub 2015 Oct 27

 Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>ivUFBKbUfAu-7</gtr:outcomeId><gtr:partnerContribution>Specific Thermogenic studies covering CNS, BAT and electrophysiology</gtr:partnerContribution><gtr:piContribution>Murine generation and Phenotyping</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Molecular mechanisms of mitochondrial biogenesis</gtr:description><gtr:id>6A34A762-37CF-4A38-8E29-85334183E35F</gtr:id><gtr:impact>Integration in FP7 Etherpath grant</gtr:impact><gtr:outcomeId>9D872B81BCD-1</gtr:outcomeId><gtr:partnerContribution>Providing animal models generated by AZaccess to lipidomic platforms</gtr:partnerContribution><gtr:piContribution>Provided biological samples for platform development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Thermogenesis</gtr:description><gtr:id>79CACF56-90E4-41D8-A40B-3209E36E01C6</gtr:id><gtr:impact>Whittle, A.J., S. Carobbio, L. Martins, M. Slawik, E. Hondares, (11 authors),A. Vidal-Puig, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell, 2012. 149(4): p. 871-85.

Lopez, M., R. Lage, A.K. Saha, D. Perez-Tilve, M.J. Vazquez, (17 authors), A. Vidal-Puig, Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab, 2008. 7(5): p. 389-99.

Lopez, M., L. Varela, M.J. Vazquez, S. Rodriguez-Cuenca, C.R. Gonzalez,(16 authors) and A. Vidal-Puig, Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med, 2010. 16(9): p. 1001-8.

 Lee EY, Sakurai K, Zhang X, Toda C, Tanaka T, Jiang M, Shirasawa T, Tachibana K, Yokote K, Vidal-Puig A, Minokoshi Y, Miki T. Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet. Sci Rep. 2015 Nov 30;5:17565. doi: 10.1038/srep17565.

4. Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A*, Bujo H*. Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nat Commun. 2015 Nov 20;6:8951. doi: 10.1038/ncomms9951.* Corresponding Author

Schreiber R, Hofer P, Taschler U, Voshol PJ, Rechberger GN, Kotzbeck P, Jaeger D, Preiss-Landl K, Lord CC, Brown JM, Haemmerle G, Zimmermann R, Vidal-Puig A, Zechner R Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity. Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13850-5. doi: 10.1073/pnas.1516004112. Epub 2015 Oct 27

 Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>ivUFBKbUfAu-3</gtr:outcomeId><gtr:partnerContribution>Specific Thermogenic studies covering CNS, BAT and electrophysiology</gtr:partnerContribution><gtr:piContribution>Murine generation and Phenotyping</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>EMBL European Bioinformatics Institute (EMBL - EBI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Bioinformatics</gtr:description><gtr:id>C3C4AB35-687A-465F-BE5D-2CA073054610</gtr:id><gtr:impact>Vivas, Y., C. Martinez-Garcia, A. Izquierdo, F. Garcia-Garcia, S. Callejas, (4 authors), A. Vidal-Puig, and G. Medina-Gomez, Early peroxisome proliferator-activated receptor gamma regulated genes involved in expansion of pancreatic beta cell mass. BMC Med Genomics, 2012. 4: p. 86.

Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice.


Prieur X, Mok CY, Velagapudi VR, N&amp;uacute;&amp;ntilde;ez V, Fuentes L, Montaner D, Ishikawa K, Camacho A, Barbarroja N, O'Rahilly S, Sethi JK, Dopazo J, Ore?ic M, Ricote M, Vidal-Puig A.Diabetes. 2011 Mar;60(3):797-809. doi: 10.2337/db10-0705. Epub 2011 Jan 24.MID: 21266330 Free PMC Article

Razzoli M, Frontini A, Gurney A, Mondini E, Cubuk C, Katz LS, Cero C, Bolan PJ, Dopazo J, Vidal-Puig A, Cinti S, Bartolomucci A.
Stress-induced activation of brown adipose tissue prevents obesity in conditions of low adaptive thermogenesis.
Mol Metab. 2015 Nov 11;5(1):19-33. doi: 10.1016/j.molmet.2015.10.005. eCollection 2016 Jan.
PMID: 26844204 Free PMC Article

Sebastian-Leon P, Vidal E, Minguez P, Conesa A, Tarazona S, Amadoz A, Armero C, Salavert F, Vidal-Puig A, Montaner D, Dopazo J.Understanding disease mechanisms with models of signaling pathway activities.
BMC Syst Biol. 2014 Oct 25;8:121. doi: 10.1186/s12918-014-0121-3.PMID: 25344409 Free PMC Article</gtr:impact><gtr:outcomeId>cvuR2rAcXB7-2</gtr:outcomeId><gtr:partnerContribution>Modelling/Bioinformatic analysis</gtr:partnerContribution><gtr:piContribution>Data generation in metabolic studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Santiago de Compostela</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Mechanisms of CNS control of Energy Balance</gtr:description><gtr:id>6BDBE100-AA04-4B49-ACEF-BD05BF9832AE</gtr:id><gtr:impact>Whittle AJ, Carobbio S, Martins L, Slawik M, Hondares E, V&amp;aacute;zquez MJ, Morgan D, Csikasz RI, Gallego R, Rodriguez-Cuenca S, Dale M, Virtue S, Villarroya F, Cannon B, Rahmouni K, L&amp;oacute;pez M, Vidal-Puig A. BMP8B Increases Brown Adipose Tissue Thermogenesis through Both Central and Peripheral Actions. Cell. 2012 May 11;149(4):871-85.

Carobbio S, Hagen RM, Lelliott CJ, Slawik M, Medina-Gomez G, Tan CY, Sicard A, Atherton HJ, Barbarroja N, Bjursell M, Bohlooly-Y M, Virtue S, Tuthill A, Lefai E, Laville M, Wu T, Considine RV, Vidal H, Langin D, Oresic M, Tinahones FJ, Fernandez-Real JM, Griffin JL, Sethi JK, L&amp;oacute;pez M, Vidal-Puig A. Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity. Diabetes 2013 Aug 6. [Epub ahead of print]

 Fern&amp;oslash; J, Varela L, Skrede S, V&amp;aacute;zquez MJ, Nogueiras R, Di&amp;eacute;guez C, Vidal-Puig A, Steen VM, L&amp;oacute;pez M. Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation. PLoS One June 13, 2011.

2. Skrede S, Fern&amp;oslash; J, V&amp;aacute;zquez MJ, Fj&amp;aelig;r S, Pavlin T, Lunder N, Vidal-Puig A, Di&amp;eacute;guez C, Berge RK, L&amp;oacute;pez M, Steen VM. Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats. Int J Neuropsychopharmacol. August, 2011.

3.Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance.

4.L&amp;oacute;pez M, Varela L, V&amp;aacute;zquez MJ, Rodr&amp;iacute;guez-Cuenca S, Gonz&amp;aacute;lez CR, Velagapudi VR, Morgan DA, Schoenmakers E, Agassandian K, Lage R, Mart&amp;iacute;nez de Morentin PB, Tovar S, Nogueiras R, Carling D, Lelliott C, Gallego R, Oresic M, Chatterjee K, Saha AK, Rahmouni K, Di&amp;eacute;guez C, Vidal-Puig A.

Nat Med. 2010 Sep;16(9):1001-8. Epub 2010 Aug 29.
PMID: 20802499 [PubMed - indexed for MEDLINE]
Related citations
5.Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender.

Lage R, V&amp;aacute;zquez MJ, Varela L, Saha AK, Vidal-Puig A, Nogueiras R, Di&amp;eacute;guez C, L&amp;oacute;pez M.

FASEB J. 2010 Aug;24(8):2670-9. Epub 2010 Mar 24.
PMID: 20335227 [PubMed - indexed for MEDLINE]
Related citations
6.AMPK: a metabolic gauge regulating whole-body energy homeostasis.

Lage R, Di&amp;eacute;guez C, Vidal-Puig A, L&amp;oacute;pez M.

Trends Mol Med. 2008 Dec;14(12):539-49. Epub 2008 Nov 1. Review.
PMID: 18977694 [PubMed - indexed for MEDLINE]
Related citations
7.Brain lipogenesis and regulation of energy metabolism.

L&amp;oacute;pez M, Vidal-Puig A.

Curr Opin Clin Nutr Metab Care. 2008 Jul;11(4):483-90. Review.
PMID: 18542011 [PubMed - indexed for MEDLINE]
Related citations
8.Central resistin regulates hypothalamic and peripheral lipid metabolism in a nutritional-dependent fashion.

9.V&amp;aacute;zquez MJ, Gonz&amp;aacute;lez CR, Varela L, Lage R, Tovar S, Sangiao-Alvarellos S, Williams LM, Vidal-Puig A, Nogueiras R, L&amp;oacute;pez M, Di&amp;eacute;guez C.

Endocrinology. 2008 Sep;149(9):4534-43. Epub 2008 May 22.
PMID: 18499762 [PubMed - indexed for MEDLINE]Free Article
Related citations
10.Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin.

11.L&amp;oacute;pez M, Lage R, Saha AK, P&amp;eacute;rez-Tilve D, V&amp;aacute;zquez MJ, Varela L, Sangiao-Alvarellos S, Tovar S, Raghay K, Rodr&amp;iacute;guez-Cuenca S, Deoliveira RM, Casta&amp;ntilde;eda T, Datta R, Dong JZ, Culler M, Sleeman MW, Alvarez CV, Gallego R, Lelliott CJ, Carling D, Tsch&amp;ouml;p MH, Di&amp;eacute;guez C, Vidal-Puig A.

Cell Metab. 2008 May;7(5):389-99.
PMID: 18460330 [PubMed - indexed for MEDLINE]
Related citations</gtr:impact><gtr:outcomeId>iuTdfRBrPXo-1</gtr:outcomeId><gtr:partnerContribution>Dr Miguel Lopez was a former fellow in my lab and now has established his own lab in Santiago. He is an expert in Neuroanatomy and as such he provides his expertise to the CNS characterisation of our genetically modified mouse mopdels</gtr:partnerContribution><gtr:piContribution>We provide the generation and metabolic charaterisation of murine models.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Regional Government of Valencia</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Pr?ncipe Felipe Research Centre (CIPF)</gtr:department><gtr:description>Bioinformatics</gtr:description><gtr:id>B137FC19-B409-4D7F-A491-4144E50CDF7F</gtr:id><gtr:impact>Vivas, Y., C. Martinez-Garcia, A. Izquierdo, F. Garcia-Garcia, S. Callejas, (4 authors), A. Vidal-Puig, and G. Medina-Gomez, Early peroxisome proliferator-activated receptor gamma regulated genes involved in expansion of pancreatic beta cell mass. BMC Med Genomics, 2012. 4: p. 86.

Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice.


Prieur X, Mok CY, Velagapudi VR, N&amp;uacute;&amp;ntilde;ez V, Fuentes L, Montaner D, Ishikawa K, Camacho A, Barbarroja N, O'Rahilly S, Sethi JK, Dopazo J, Ore?ic M, Ricote M, Vidal-Puig A.Diabetes. 2011 Mar;60(3):797-809. doi: 10.2337/db10-0705. Epub 2011 Jan 24.MID: 21266330 Free PMC Article

Razzoli M, Frontini A, Gurney A, Mondini E, Cubuk C, Katz LS, Cero C, Bolan PJ, Dopazo J, Vidal-Puig A, Cinti S, Bartolomucci A.
Stress-induced activation of brown adipose tissue prevents obesity in conditions of low adaptive thermogenesis.
Mol Metab. 2015 Nov 11;5(1):19-33. doi: 10.1016/j.molmet.2015.10.005. eCollection 2016 Jan.
PMID: 26844204 Free PMC Article

Sebastian-Leon P, Vidal E, Minguez P, Conesa A, Tarazona S, Amadoz A, Armero C, Salavert F, Vidal-Puig A, Montaner D, Dopazo J.Understanding disease mechanisms with models of signaling pathway activities.
BMC Syst Biol. 2014 Oct 25;8:121. doi: 10.1186/s12918-014-0121-3.PMID: 25344409 Free PMC Article</gtr:impact><gtr:outcomeId>cvuR2rAcXB7-1</gtr:outcomeId><gtr:partnerContribution>Modelling/Bioinformatic analysis</gtr:partnerContribution><gtr:piContribution>Data generation in metabolic studies</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Nutrition Research Unit</gtr:department><gtr:description>Lipidomic technology</gtr:description><gtr:id>A38A6DEC-8111-4284-9280-F5339277B617</gtr:id><gtr:impact>1.Medina-Gomez G, Yetukuri L, Velagapudi V, Campbell M, Blount M, Jimenez-Linan M, Ros M, Oresic M, Vidal-Puig A. Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome. Dis Model Mech. 2009 Nov-Dec;2(11-12):582-92. Epub 2009 Oct 19. PMID: 19841237 2.Tang J, Tan CY, Oresic M, Vidal-Puig A.Integrating post-genomic approaches as a strategy to advance our understanding of health and disease.Genome Med. 2009 Mar 30;1(3):35.PMID: 19341506 3.Oresic M, H&amp;auml;nninen VA, Vidal-Puig A.Lipidomics: a new window to biomedical frontiers. Trends Biotechnol. 2008 Dec;26(12):647-52. Epub 2008 Oct 23. PMID: 18951641 4.Yetukuri L, Ekroos K, Vidal-Puig A, Oresic M.Informatics and computational strategies for the study of lipids. Mol Biosyst. 2008 Feb;4(2):121-7. PMID: 18213405 5.Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, Jimenez-Linan M, Blount M, Yeo GS, Lopez M, Sepp&amp;auml;nen-Laakso T, Ashcroft FM, Oresic M, Vidal-Puig A.PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.PLoS Genet. 2007 Apr 27;3(4):e64. PMID: 17465682 6.Yetukuri L, Katajamaa M, Medina-Gomez G, Sepp&amp;auml;nen-Laakso T, Vidal-Puig A, Oresic M.Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis.BMC Syst Biol. 2007 Feb 15;1:12. PMID: 17408502 7.Lelliott CJ, Medina-Gomez G, Petrovic N, Kis A, Feldmann HM, Bjursell M, Parker N, Curtis K, Campbell M, Hu P, Zhang D, Litwin SE, Zaha VG, Fountain KT, Boudina S, Jimenez-Linan M, Blount M, Lopez M, Meirhaeghe A, Bohlooly-Y M, Storlien L, Str&amp;ouml;mstedt M, Snaith M, Oresic M, Abel ED, Cannon B, Vidal-Puig A.Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance.PLoS Biol. 2006 Nov;4(11):e369.PMID: 17090215 8.Oresic M, Vidal-Puig A, H&amp;auml;nninen V. Metabolomic approaches to phenotype characterization and applications to complex diseases.Expert Rev Mol Diagn. 2006 Jul;6(4):575-85. Review. PMID: 16824031 

15. Virtue S, F.H., Christian M, Tan CY, Masoodi M, Dale M, et al (10 authors) Vidal-Puig A. Diabetes in press (2012), A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes, (2012.)

Virtue, S., M. Christian, C. Tan, M. Masoodi, M. Dale, C. ( 10 authors) A. Vidal-Puig, A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes 2012.

Griffin, J.L. and A. Vidal-Puig, Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding? Physiol Genomics, 2008. 34(1): p. 1-5.

Pietilainen, K.H., T. Rog, T. Seppanen-Laakso, S. Virtue, P. Gopalacharyulu, J.(16 authors), A. Vidal-Puig, and M. Oresic, Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol, 2011. 9(6): p. e1000623.
19. Prieur, X., C.Y. Mok, V.R. Velagapudi, V. Nunez, L. Fuentes, D. (9 authors), A. Vidal-Puig, Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes, 2011. 60(3): p. 797-809.
20. Kilpelainen, T.O., M.C. Zillikens, A. Stancakova, F.M. Finucane, J.S. Ried, C. Langenberg, (65 authors) A. Vidal-Puig, (40 authors) R.J. Loos, Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet, 2011. 43(8): p. 753-60.
21. Medina-Gomez, G., L. Yetukuri, V. Velagapudi, M. Campbell, M. Blount,et al (3 authors), A. Vidal-Puig, Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome. Dis Model Mech, 2009. 2(11-12): p. 582-92.
22. Vivas, Y., C. Martinez-Garcia, A. Izquierdo, F. Garcia-Garcia, S. Callejas, (4 authors), A. Vidal-Puig, and G. Medina-Gomez, Early peroxisome proliferator-activated receptor gamma regulated genes involved in expansion of pancreatic beta cell mass. BMC Med Genomics, 2012. 4: p. 86.
Virtue S, Feldmann H, Christian M, Tan CY, Masoodi M, Dale M, Lelliott C, Burling K, Campbell M, Eguchi N, Voshol P, Sethi JK, Parker M, Urade Y, Griffin JL, Cannon B, Vidal-Puig A. A new role for Lipocalin Prostaglandin D Synthase in the regulation of brown adipose tissue substrate utilisation. Diabetes 61(12):3139-47 (2012).

4. Carobbio S, Hagen RM, Lelliott CJ, Slawik M, Medina-Gomez G, Tan CY, Sicard A, Atherton HJ, Barbarroja N, Bjursell M, Bohlooly-Y M, Virtue S, Tuthill A, Lefai E, Laville M, Wu T, Considine RV, Vidal H, Langin D, Oresic M, Tinahones FJ, Fernandez-Real JM, Griffin JL, Sethi JK, L&amp;oacute;pez M, Vidal-Puig A. Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity. Diabetes 2013 Aug 6. [Epub ahead of print]

12. Virtue S, Masoodi M, Velagapudi V, Tan CY, Dale M, Suorti T, Slawik M, Blount M, Burling K, Campbell M, Eguchi N, Medina-Gomez G, Sethi JK, Ore?ic M, Urade Y, Griffin JL, Vidal-Puig A. Lipocalin Prostaglandin D Synthase and PPAR?2 Coordinate to Regulate Carbohydrate and Lipid Metabolism In Vivo. PLoS One 7(7):e39512. (2012)

Rodriguez-Cuenca S, Carobbio S, Velagapudi VR, Barbarroja N, Moreno-Navarrete JM, Tinahones FJ, Fernandez-Real JM, Oresic M, Vidal-Puig A. PPAR? DEPENDENT REGULATION OF LIPOLYTIC NODES AND METABOLIC FLEXIBILITY. Moll Cell Biol. 2012 Feb 6.</gtr:impact><gtr:outcomeId>CDC21732DE6-2</gtr:outcomeId><gtr:partnerContribution>Providing lipidomic analysis from biological samples.</gtr:partnerContribution><gtr:piContribution>provided intellectual framework, experimental design and biological samples.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Newcastle</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Thermogenesis</gtr:description><gtr:id>1996E40B-B826-4F46-8927-FE6E71D837BD</gtr:id><gtr:impact>Whittle, A.J., S. Carobbio, L. Martins, M. Slawik, E. Hondares, (11 authors),A. Vidal-Puig, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell, 2012. 149(4): p. 871-85.

Lopez, M., R. Lage, A.K. Saha, D. Perez-Tilve, M.J. Vazquez, (17 authors), A. Vidal-Puig, Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab, 2008. 7(5): p. 389-99.

Lopez, M., L. Varela, M.J. Vazquez, S. Rodriguez-Cuenca, C.R. Gonzalez,(16 authors) and A. Vidal-Puig, Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med, 2010. 16(9): p. 1001-8.

 Lee EY, Sakurai K, Zhang X, Toda C, Tanaka T, Jiang M, Shirasawa T, Tachibana K, Yokote K, Vidal-Puig A, Minokoshi Y, Miki T. Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet. Sci Rep. 2015 Nov 30;5:17565. doi: 10.1038/srep17565.

4. Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A*, Bujo H*. Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nat Commun. 2015 Nov 20;6:8951. doi: 10.1038/ncomms9951.* Corresponding Author

Schreiber R, Hofer P, Taschler U, Voshol PJ, Rechberger GN, Kotzbeck P, Jaeger D, Preiss-Landl K, Lord CC, Brown JM, Haemmerle G, Zimmermann R, Vidal-Puig A, Zechner R Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity. Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13850-5. doi: 10.1073/pnas.1516004112. Epub 2015 Oct 27

 Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>ivUFBKbUfAu-6</gtr:outcomeId><gtr:partnerContribution>Specific Thermogenic studies covering CNS, BAT and electrophysiology</gtr:partnerContribution><gtr:piContribution>Murine generation and Phenotyping</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Stockholm University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Werner Institute</gtr:department><gtr:description>Thermogenesis</gtr:description><gtr:id>0C13AF02-EA88-4290-8A46-ECFF607E2826</gtr:id><gtr:impact>Whittle, A.J., S. Carobbio, L. Martins, M. Slawik, E. Hondares, (11 authors),A. Vidal-Puig, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell, 2012. 149(4): p. 871-85.

Lopez, M., R. Lage, A.K. Saha, D. Perez-Tilve, M.J. Vazquez, (17 authors), A. Vidal-Puig, Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab, 2008. 7(5): p. 389-99.

Lopez, M., L. Varela, M.J. Vazquez, S. Rodriguez-Cuenca, C.R. Gonzalez,(16 authors) and A. Vidal-Puig, Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med, 2010. 16(9): p. 1001-8.

 Lee EY, Sakurai K, Zhang X, Toda C, Tanaka T, Jiang M, Shirasawa T, Tachibana K, Yokote K, Vidal-Puig A, Minokoshi Y, Miki T. Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet. Sci Rep. 2015 Nov 30;5:17565. doi: 10.1038/srep17565.

4. Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A*, Bujo H*. Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nat Commun. 2015 Nov 20;6:8951. doi: 10.1038/ncomms9951.* Corresponding Author

Schreiber R, Hofer P, Taschler U, Voshol PJ, Rechberger GN, Kotzbeck P, Jaeger D, Preiss-Landl K, Lord CC, Brown JM, Haemmerle G, Zimmermann R, Vidal-Puig A, Zechner R Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity. Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13850-5. doi: 10.1073/pnas.1516004112. Epub 2015 Oct 27

 Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>ivUFBKbUfAu-2</gtr:outcomeId><gtr:partnerContribution>Specific Thermogenic studies covering CNS, BAT and electrophysiology</gtr:partnerContribution><gtr:piContribution>Murine generation and Phenotyping</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>macrophage</gtr:description><gtr:id>F59F9C95-A952-4CA6-9F7E-6CF0EB48848B</gtr:id><gtr:impact>Prieur, X., C.Y. Mok, V.R. Velagapudi, V. Nunez, L. Fuentes, D. (9 authors), A. Vidal-Puig, Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes, 2011. 60(3): p. 797-809.

Virtue S, Masoodi M, de Weijer BA, van Eijk M, Mok CY, Eiden M, Dale M, Pirraco A, Serlie MJ, Griffin JL, Vidal-Puig A. Prostaglandin profiling reveals a role for haematopoietic prostaglandin D synthase in adipose tissue macrophage polarisation in mice and humans. Int J Obes (Lond). 2015 Mar 24. doi: 10.1038/ijo.2015.34</gtr:impact><gtr:outcomeId>kndLTkqnPaz-2</gtr:outcomeId><gtr:partnerContribution>Generation of murine models targeting specific genetic modification to macrophages</gtr:partnerContribution><gtr:piContribution>Generation of original mouse models and characterisation</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Spanish Ministry of Health and Consumer Affairs</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>National Center for Cardiovascular Research (CNIC)</gtr:department><gtr:description>macrophage</gtr:description><gtr:id>E366EBD4-DD38-4EFB-A69E-6954C0479C67</gtr:id><gtr:impact>Prieur, X., C.Y. Mok, V.R. Velagapudi, V. Nunez, L. Fuentes, D. (9 authors), A. Vidal-Puig, Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes, 2011. 60(3): p. 797-809.

Virtue S, Masoodi M, de Weijer BA, van Eijk M, Mok CY, Eiden M, Dale M, Pirraco A, Serlie MJ, Griffin JL, Vidal-Puig A. Prostaglandin profiling reveals a role for haematopoietic prostaglandin D synthase in adipose tissue macrophage polarisation in mice and humans. Int J Obes (Lond). 2015 Mar 24. doi: 10.1038/ijo.2015.34</gtr:impact><gtr:outcomeId>kndLTkqnPaz-1</gtr:outcomeId><gtr:partnerContribution>Generation of murine models targeting specific genetic modification to macrophages</gtr:partnerContribution><gtr:piContribution>Generation of original mouse models and characterisation</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>German Cancer Research Center</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Flies as a disease model to study metabolic disease</gtr:description><gtr:id>83ED28B6-AA6E-4FE1-9A8B-850262C59063</gtr:id><gtr:impact>Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>58b97d594c8467.91167921-1</gtr:outcomeId><gtr:partnerContribution>generation of genetically modified flies mimicking mouse or cell genetic modification.</gtr:partnerContribution><gtr:piContribution>provide hypothesis for validation in flies and also perform experiments in mammalian systems with insights coming from flies.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>German Cancer Research Center</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Thermogenesis</gtr:description><gtr:id>A37F6099-EC71-479B-B38E-18747AC32F28</gtr:id><gtr:impact>Whittle, A.J., S. Carobbio, L. Martins, M. Slawik, E. Hondares, (11 authors),A. Vidal-Puig, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell, 2012. 149(4): p. 871-85.

Lopez, M., R. Lage, A.K. Saha, D. Perez-Tilve, M.J. Vazquez, (17 authors), A. Vidal-Puig, Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab, 2008. 7(5): p. 389-99.

Lopez, M., L. Varela, M.J. Vazquez, S. Rodriguez-Cuenca, C.R. Gonzalez,(16 authors) and A. Vidal-Puig, Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med, 2010. 16(9): p. 1001-8.

 Lee EY, Sakurai K, Zhang X, Toda C, Tanaka T, Jiang M, Shirasawa T, Tachibana K, Yokote K, Vidal-Puig A, Minokoshi Y, Miki T. Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet. Sci Rep. 2015 Nov 30;5:17565. doi: 10.1038/srep17565.

4. Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A*, Bujo H*. Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nat Commun. 2015 Nov 20;6:8951. doi: 10.1038/ncomms9951.* Corresponding Author

Schreiber R, Hofer P, Taschler U, Voshol PJ, Rechberger GN, Kotzbeck P, Jaeger D, Preiss-Landl K, Lord CC, Brown JM, Haemmerle G, Zimmermann R, Vidal-Puig A, Zechner R Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity. Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13850-5. doi: 10.1073/pnas.1516004112. Epub 2015 Oct 27

 Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>ivUFBKbUfAu-9</gtr:outcomeId><gtr:partnerContribution>Specific Thermogenic studies covering CNS, BAT and electrophysiology</gtr:partnerContribution><gtr:piContribution>Murine generation and Phenotyping</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mario Negri Institute for Pharmacological Research</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Mitochondria metabolism</gtr:description><gtr:id>F8C6F151-9F40-4F29-B78E-7BA8C5CC900B</gtr:id><gtr:impact>D'Errico I, Salvatore L, Murzilli S, Lo Sasso G, Latorre D, Martelli N, Egorova AV, Polishuck R, Madeyski-Bengtson K, Lelliott C, Vidal-Puig AJ, Seibel P, Villani G, Moschetta A. Peroxisome proliferator-activated receptor-{gamma} coactivator 1-{alpha} (PGC1{alpha}) is a metabolic regulator of intestinal epithelial cell fate. Proc Natl Acad Sci USA April 5, 2011</gtr:impact><gtr:outcomeId>e8dY34PsdUJ-1</gtr:outcomeId><gtr:partnerContribution>Current collaboration on the characterisation of the effects of PGC1b in gut and liver,</gtr:partnerContribution><gtr:piContribution>Exchange of murine models and reagents as well as intellectual exchange.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chiba University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Thermogenesis</gtr:description><gtr:id>ABB82BC7-23F5-4283-ACBF-3861CC17959F</gtr:id><gtr:impact>Whittle, A.J., S. Carobbio, L. Martins, M. Slawik, E. Hondares, (11 authors),A. Vidal-Puig, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell, 2012. 149(4): p. 871-85.

Lopez, M., R. Lage, A.K. Saha, D. Perez-Tilve, M.J. Vazquez, (17 authors), A. Vidal-Puig, Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab, 2008. 7(5): p. 389-99.

Lopez, M., L. Varela, M.J. Vazquez, S. Rodriguez-Cuenca, C.R. Gonzalez,(16 authors) and A. Vidal-Puig, Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med, 2010. 16(9): p. 1001-8.

 Lee EY, Sakurai K, Zhang X, Toda C, Tanaka T, Jiang M, Shirasawa T, Tachibana K, Yokote K, Vidal-Puig A, Minokoshi Y, Miki T. Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet. Sci Rep. 2015 Nov 30;5:17565. doi: 10.1038/srep17565.

4. Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A*, Bujo H*. Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nat Commun. 2015 Nov 20;6:8951. doi: 10.1038/ncomms9951.* Corresponding Author

Schreiber R, Hofer P, Taschler U, Voshol PJ, Rechberger GN, Kotzbeck P, Jaeger D, Preiss-Landl K, Lord CC, Brown JM, Haemmerle G, Zimmermann R, Vidal-Puig A, Zechner R Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity. Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13850-5. doi: 10.1073/pnas.1516004112. Epub 2015 Oct 27

 Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>ivUFBKbUfAu-5</gtr:outcomeId><gtr:partnerContribution>Specific Thermogenic studies covering CNS, BAT and electrophysiology</gtr:partnerContribution><gtr:piContribution>Murine generation and Phenotyping</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Zora Biosciences Oy</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:description>Molecular mechanisms of mitochondrial biogenesis</gtr:description><gtr:id>5848D46C-E5C4-4591-84FC-AF7D0C42980E</gtr:id><gtr:impact>Integration in FP7 Etherpath grant</gtr:impact><gtr:outcomeId>9D872B81BCD-3</gtr:outcomeId><gtr:partnerContribution>Providing animal models generated by AZaccess to lipidomic platforms</gtr:partnerContribution><gtr:piContribution>Provided biological samples for platform development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Osaka University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>LPGD2S KO MOUSe</gtr:description><gtr:id>F26690A6-82FB-434B-9E23-60E1B041C9B1</gtr:id><gtr:impact>Papers still under submission expected to be published during 2010</gtr:impact><gtr:outcomeId>1B72A8A6CCB-1</gtr:outcomeId><gtr:partnerContribution>provided animal models for MRC funded project.</gtr:partnerContribution><gtr:piContribution>Phenotyping of mouse models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Graz</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Institute of Molecular Biosciences</gtr:department><gtr:description>Thermogenesis</gtr:description><gtr:id>E8C69F30-776C-41BB-866D-3DFA40CCA0EB</gtr:id><gtr:impact>Whittle, A.J., S. Carobbio, L. Martins, M. Slawik, E. Hondares, (11 authors),A. Vidal-Puig, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell, 2012. 149(4): p. 871-85.

Lopez, M., R. Lage, A.K. Saha, D. Perez-Tilve, M.J. Vazquez, (17 authors), A. Vidal-Puig, Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab, 2008. 7(5): p. 389-99.

Lopez, M., L. Varela, M.J. Vazquez, S. Rodriguez-Cuenca, C.R. Gonzalez,(16 authors) and A. Vidal-Puig, Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med, 2010. 16(9): p. 1001-8.

 Lee EY, Sakurai K, Zhang X, Toda C, Tanaka T, Jiang M, Shirasawa T, Tachibana K, Yokote K, Vidal-Puig A, Minokoshi Y, Miki T. Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet. Sci Rep. 2015 Nov 30;5:17565. doi: 10.1038/srep17565.

4. Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A*, Bujo H*. Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. Nat Commun. 2015 Nov 20;6:8951. doi: 10.1038/ncomms9951.* Corresponding Author

Schreiber R, Hofer P, Taschler U, Voshol PJ, Rechberger GN, Kotzbeck P, Jaeger D, Preiss-Landl K, Lord CC, Brown JM, Haemmerle G, Zimmermann R, Vidal-Puig A, Zechner R Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity. Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13850-5. doi: 10.1073/pnas.1516004112. Epub 2015 Oct 27

 Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>ivUFBKbUfAu-8</gtr:outcomeId><gtr:partnerContribution>Specific Thermogenic studies covering CNS, BAT and electrophysiology</gtr:partnerContribution><gtr:piContribution>Murine generation and Phenotyping</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MUJER HOY Engorda La Calefaccion</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0D14B6F0-52E5-4C1E-9CEF-F865776FE4A9</gtr:id><gtr:impact>Dos &amp;oacute;rganos distintos: Grasa blanca y grasa parda

1. La grasa blanca es el &amp;oacute;rgano donde se acumula el exceso de energ&amp;iacute;a para que el organismo la utilice cuando la necesita. Los problemas ocurren cuando ese tejido adiposo blanco se satura y es incapaz de retener m&amp;aacute;s grasa, con lo que esta empieza a acumularse en otros &amp;oacute;rganos, como el h&amp;iacute;gado o el m&amp;uacute;sculo, produciendo diabetes, h&amp;iacute;gado graso y otros problemas de salud. 

2. La grasa parda es un &amp;oacute;rgano dise&amp;ntilde;ado para producir calor. Est&amp;aacute; presente en los reci&amp;eacute;n nacidos porque son muy vulnerables frente al fr&amp;iacute;o, y tienen que producir calor para mantener la temperatura corporal adecuada. Lo que se ha observado recientemente es que tambi&amp;eacute;n la tienen algunos adultos. El equipo del profesor Vidal-Puig y otros est&amp;aacute;n estudiando la posibilidad de desarrollar un f&amp;aacute;rmaco capaz de estimular la producci&amp;oacute;n de grasa parda. &amp;quot;El potencial es grande y la posibilidad de efectos secundarios, escasa&amp;quot;, explica el experto.</gtr:impact><gtr:outcomeId>56d2cf32108cb8.81042198</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.mujerhoy.com/salud/consulta/engorda-calefaccion-714703022013.html</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge, UK. 13th April 2015. BHF Centre of Research Annual Symposium.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CB655C00-EC24-4335-9181-D8A341CD0854</gtr:id><gtr:impact>http://www.cardiovascular.cam.ac.uk/
The overarching scientific objective of the Centre is to advance understanding of pathobiology, diagnosis, prevention and therapy of selected common and rare cardiovascular conditions by applying our combined expertise in generating assumption-free approaches.</gtr:impact><gtr:outcomeId>56d20038d021b1.31686599</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.cardiovascular.cam.ac.uk/research/cambridgecre</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2A7C5D5A-877E-4EBA-A1D1-278FA6C51D63</gtr:id><gtr:impact>Edmonton, Canada. 2nd May 2016. Distinguished Speaker Lecture, University of Alberta. !50 approx. students and post docts attended lecture.</gtr:impact><gtr:outcomeId>58b98053e88623.44309685</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> CNIC Conference &quot;Energy homeostasis and metabolic disease&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2B2E56F4-4555-4EB7-BBEB-64D3BD7A44E4</gtr:id><gtr:impact>7th - 8th November 2014. CNIC Conference &amp;quot;Energy homeostasis and metabolic disease&amp;quot;
Madrid, Spain
Organisers: Mercedes Ricote, Guadalupe Sabio, Antonio Vidal-Puig
150 attendants

International visibility</gtr:impact><gtr:outcomeId>54551690cf14e7.32759118</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>workshop facilitator</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/upcoming-conferences-organised-by-prof-vidal-puig/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Turku, Finland. 28th January 2016. Frontiers of Science Seminar Series at Biocity Turku</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A3D4B4A6-EFCE-4D2D-8412-96BBC599FE23</gtr:id><gtr:impact>http://www.biocity.turku.fi/index.php?id=858
Thursday, January 28
Prof. Antonio Vidal-Puig, University of Cambridge, MRC Institute of Metabolic Science, Cambridge, UK
&amp;quot;Adipose tissue expandability, lipotoxicity and the metabolic syndrome&amp;quot;
Host: Matej Oresic (mtjo(at)steno.dk)</gtr:impact><gtr:outcomeId>56d308c5836148.28529677</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.biocity.turku.fi/index.php?id=858</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DAILy MAIL ON LR11</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>45145C5A-5193-45C2-B265-B5BAC1B33B2E</gtr:id><gtr:impact>Why the bigger you are, the HARDER it is to lose weight: Stored fat 'fights against the body's attempts to shed the pounds'
Fat cells produce the protein sLR11 which inhibits thermogenesis
This is a process by which fat cells burn calories for energy 
The more fat a person has, the more protein will be produced and the less calories burned, preventing weight loss
Experts: Finding could help treat conditions such as obesity and diabetes
By Madlen Davies for MailOnline 
Published: 17:04, 24 November 2015 | Updated: 17:57, 24 November 2015 
Read more: http://www.dailymail.co.uk/health/article-3331892/Why-bigger-harder-lose-weight-Stored-fat-fights-against-body-s-attempts-shed-pounds.html#ixzz41SHV7aRj 
Follow us: @MailOnline on Twitter | DailyMail on Facebook</gtr:impact><gtr:outcomeId>56d2c2df06c225.79553306</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.dailymail.co.uk/health/article-3331892/Why-bigger-harder-lose-weight-Stored-fat-fights-against-body-s-attempts-shed-pounds.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Japan, 2015. 21st-24th May 2015. 58th Annual Meeting of the Japan Diabetes Society: Evolution and Deepening of Diabetology.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>94DA079D-C24C-4DD7-B34F-2E035F505124</gtr:id><gtr:impact>4. Japan, 2015. 21st-24th May 2015. 58th Annual Meeting of the Japan Diabetes Society: Evolution and Deepening of Diabetology.</gtr:impact><gtr:outcomeId>56d2056db14b71.51760288</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.jds.or.jp/modules/en/index.php?content_id=45</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog BAT 2</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>17D99837-5061-4648-BC6A-1C16C0B67411</gtr:id><gtr:impact>Blog from Sanger wich bord reach where we presented our research on brown fat

From clinical studies and animal models, scientists have noticed that some obese individuals can maintain a remarkable capacity to store fat before experiencing adverse metabolic effects associated with obesity, such as insulin resistance and Type 2 diabetes. It seems that the adipose tissue of these people has developed adaptive mechanisms that allow it to preserve its functionality while adjusting its biochemical features to maintain its biophysical characteristics. Read more here.

 Blog by</gtr:impact><gtr:outcomeId>5455117b39c599.07166199</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Keystone Symposia on Diabetes/Obesity and Adipose Tissue Biology.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4A6A72B1-3BCD-4925-A5AD-CC32BB281437</gtr:id><gtr:impact>. Colorado, USA. 22nd - 27th January 2017. Keystone Symposia on Diabetes/Obesity and Adipose Tissue Biology.</gtr:impact><gtr:outcomeId>58b982c2d25053.22864172</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>30th September  14th Annual Cambridge Immunology Forum Meeting  Cambridge, UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>29EF784E-5A9B-4692-A37A-3D527D72C127</gtr:id><gtr:impact>14th Annual Cambridge Immunology Forum Meeting
Organisers: Marc Veldhoen, Arthur Kaser, Toni Vidal-Puig, Brian Ferguson

Increased knowledge and projection of the lab</gtr:impact><gtr:outcomeId>5455178eb2f553.88087766</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/upcoming-conferences-organised-by-prof-vidal-puig/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> British Atherosclerosis Society Meeting: 'Atherosclerosis: crossroads of metabolism and inflammation'.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EE32EA14-8DAD-4A40-B58C-62F6B5CAD8AE</gtr:id><gtr:impact>British Atherosclerosis Society Meeting: 'Atherosclerosis: crossroads of metabolism and inflammation'. 
British Atherosclerosis Society Autumn Meeting 2015


Atherosclerosis: Crossroads of Metabolism and Inflammation

Meeting Report

Organisers: Joseph Boyle, Ashley Miller, Martin Bennett
Date: Thursday 10th - Friday 11th September 2015
Venue: Murray Edwards College, New Hall, University of Cambridge, Cambridge
Final Programme
Sponsors: Amgen has provided unrestricted funding to support this meeting. Amgen has had no input into the programme, selection of speakers or topics.</gtr:impact><gtr:outcomeId>56d1fc8ae16502.86612881</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.britathsoc.org/previous-meetings/british-atherosclerosis-society-autumn-meeting-2015/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> 12th National Congress of the Spanish Society for the Study of Obesity.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0F1E8BEE-F225-47E8-8394-13A0E135840C</gtr:id><gtr:impact>12th National Congress of the Spanish Society for the Study of Obesity.</gtr:impact><gtr:outcomeId>56d1fbde1c5098.73229807</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> EAS Advanced Course in Cardiometabolic Phenotyping in Rodents.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6E17F602-2E73-4CA2-B54A-B2466CB2B2F5</gtr:id><gtr:impact>EAS Advanced in Cardiometabolic Phenotyping in Rodents, Cambridge, UK

Scientists from the University of Cambridge Biomedical Campus recently hosted the 2nd EAS Advanced Course in Cardiometabolic Phenotyping in Rodents. This 3-day course combines the state of the art facilities and expertise within the Disease Model Core at the WellcomeTrust-MRC Institute of Metabolic Science and the BHF Cardiovascular Centre. By integrating the expertise of these two specialized phenotyping centres, it provides a unique opportunity to learn about many of the skills required for in depth cardiometabolic phenotyping in small animals. 

The 32 participants, selected from centres across Europe, were treated to a programme of lectures, phenotyping demonstrations and data analysis sessions. A further 1-day workshop at the Sanger/EBI focused on mouse genetics, genetic engineering and informatics resources, highlighting the great opportunities provided by recent advances in genetic engineering purpose-made mouse models. Participants particularly appreciated the mixture of hands-on experience, combined with opportunities to ask detailed questions on how the techniques demonstrated should be used to suit their own research priorities.

The course was sponsored by the European Atherosclerosis Society, British Heart Foundation and TSE systems, with organisation led by Prof Toni Vidal-Puig, Director of the MRC Metabolic Diseases Unit Disease Model Core.</gtr:impact><gtr:outcomeId>56d201a73b4213.24621581</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://tvp.mrl.ims.cam.ac.uk/events/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>3. Tsukuba, Japan. 17th-19th September 2016. Tsukuba Global Science Week.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8128A128-239C-48CB-A77A-E7CAB879F72A</gtr:id><gtr:impact>Tsukuba, Japan. 17th-19th September 2016. Tsukuba Global Science Week.</gtr:impact><gtr:outcomeId>58b981f751d4a8.64003747</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Malaga, Spain. 19th - 21st October 2016. Congress of the Spanish Society of Endocrinology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5C3B842F-A3D3-4F3D-A79F-4BC7D57298BB</gtr:id><gtr:impact>Malaga, Spain. 19th - 21st October 2016. Congress of the Spanish Society of Endocrinology</gtr:impact><gtr:outcomeId>58b98398b08817.10851895</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Maranon Lecture Award</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>701B76CA-7459-4D95-A971-A5FDFA27C74E</gtr:id><gtr:impact>Maranon Lecture Award de la Sociedad Espanola de Endocrinologia y Nutricion. Granada, Spain. 15th-17th May 2013.

-</gtr:impact><gtr:outcomeId>Yu7aaWAufLC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Antalya, Turkey. 23rd-26th October 2014. Endobridge.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5F0B2F0E-F3E1-4CE5-AE34-E38014CD991E</gtr:id><gtr:impact>ENDOBRIDGE 2014, 2nd EndoBridge Meeting is one of the extensive event on Pituitary Disease, Thyroid Disorders, Obesity, Endocrinology, Endocrine, Medical, Hormone Research, Hormonal Systems, Ageing, Bone And Osteoporosis, Diabetes, Hormones, Paediatric Endocrinology, Puberty, Steroids and Testosterone segments. 
2nd EndoBridge Meeting is organized annually.</gtr:impact><gtr:outcomeId>56d2bfc71d24b3.12466745</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://eventegg.com/endobridge-2014/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>. Cambridge, UK. 11th April 2016. British Heart Foundation Cardiovascular Research Excellence Annual Event.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>345D838F-DD73-401B-9474-06B609D36C11</gtr:id><gtr:impact>4. Cambridge, UK. 11th April 2016. British Heart Foundation Cardiovascular Research Excellence Annual Event.</gtr:impact><gtr:outcomeId>58b98346c7da56.88258600</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Engordar La ciencia Asturias</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CA1C8891-5BDB-4A9D-BE40-0C3F1709C59D</gtr:id><gtr:impact>Engordar la ciencia
El endocrino Antonio Vidal-Puig reivindica el valor econ&amp;oacute;mico de la investigaci&amp;oacute;n al recibir el premio del Colegio de M&amp;eacute;dicos
El endocrin&amp;oacute;logo Antonio Vidal-Puig, catedr&amp;aacute;tico de la Universidad de Cambridge y uno de los mayores expertos del mundo en obesidad, aprovech&amp;oacute; la conferencia con la que recibi&amp;oacute; ayer en Oviedo el Premio Internacional Hip&amp;oacute;crates Central Lechera Asturiana de la Real Academia de Medicina y Cirug&amp;iacute;a para reclamar un mayor apoyo a la actividad investigadora en Espa&amp;ntilde;a. &amp;quot;Los pa&amp;iacute;ses que no tienen grandes recursos naturales dependen de la econom&amp;iacute;a del conocimiento, y nosotros podemos ser econ&amp;oacute;micamente m&amp;aacute;s potentes gracias a la ciencia&amp;quot;, subray&amp;oacute; Vidal-Puig, que pertenece a 21 comit&amp;eacute;s internacionales de expertos y ha publicado 220 art&amp;iacute;culos en revistas especializadas</gtr:impact><gtr:outcomeId>56d2c70ce57666.92725084</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.lne.es/asturias/2015/11/27/engordar-ciencia/1847307.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>15th European Congress of Endocrinology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>00B2A76C-4842-4374-BC8D-B517A647F225</gtr:id><gtr:impact>15th European Congress of Endocrinology, Copenhagen, Denmark. 27th April - 1st May 2013.

As organiser of the conference we contributed to the impact on 3000 attendees.</gtr:impact><gtr:outcomeId>gbCB3QutbrT</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://www.ece2013.org/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cherry Hinton Lions Under 10s Blue Football Club sponsored by IMS/TVP lab</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D5986D80-F0B7-41FB-9920-9396C9804F97</gtr:id><gtr:impact>This is an action to promote fitness in children as a strategy to prevent orreverse obesity

Children know what is the IMS and that obesity and diabetes can be prevented by exercise.</gtr:impact><gtr:outcomeId>545513c0e79805.83475302</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>London, UK. 11th March 2015. Diabetes UK for the Adipose Plenary Conference.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2417868D-F4CF-47E4-A7B2-324FEEF4F5EC</gtr:id><gtr:impact>The Diabetes UK Professional Conference, organized by the Diabetes UK will take place from 11th March to the 13th March 2015 at the Excel London in London, United Kingdom. The conference will cover areas like basic science, clinical science, education, clinical care management, healthcare delivery and psychological care.</gtr:impact><gtr:outcomeId>56d200d3bf6546.01479053</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://10times.com/diabetes-uk-professional-conference</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog BAT</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FA82068E-D018-4DC9-B541-A634CB680308</gtr:id><gtr:impact>Blog from Sanger wich bord reach where we presented our research on brown fat

From clinical studies and animal models, scientists have noticed that some obese individuals can maintain a remarkable capacity to store fat before experiencing adverse metabolic effects associated with obesity, such as insulin resistance and Type 2 diabetes. It seems that the adipose tissue of these people has developed adaptive mechanisms that allow it to preserve its functionality while adjusting its biochemical features to maintain its biophysical characteristics. Read more here.

 Blog by</gtr:impact><gtr:outcomeId>5455117e311dc1.11948341</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Advisory Board Meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1CAF8BD9-0CAE-45C3-A34D-0B332499F0DC</gtr:id><gtr:impact>EASO Scientific Advisory Board Meeting 
18th - 19th March 2013, Brussels


redefinitionn of obesity on the baseis of body composition. BMI considered obsolete.</gtr:impact><gtr:outcomeId>KQ52cyyADXd</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CNN interview about LR11</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2A7ED3DD-9E6F-4428-9B4A-F1AA06484B3F</gtr:id><gtr:impact>New protein could help burn fat faster
By Meera Senthilingam, for CNN
Updated 1109 GMT (1909 HKT) February 1, 2016 
 (CNN)-Research has shown that the fatter your body becomes, the harder it becomes to burn that excess fat. 
As people eat more fat than they burn, the body stores this excess in various parts of the body and as this storage increases, metabolism changes.

However, all is not lost: a recent study by researchers at the University of Cambridge identified one of the proteins underlying this blockage of fat burn. &amp;quot;[This protein] is part of the system in place to help the body store more energy,&amp;quot; says Antonio Vidal-Puig, Professor in Molecular Nutrition and Metabolism, who worked on the study. 

The culprit, called sLR11, was found to block the functioning of brown fat cells -- responsible for generating heat to keep us warm -- and instead help the body store fat more efficiently by preventing excessive heat generation. 


The benefits of brown fat








There are two forms of fat cells -- brown cells and white cells -- and each plays a different role in our metabolism. 



While brown cells help generate heat, the white cells are responsible for the storage of fat -- or energy -- ready for release as needed. Levels of brown fat are known to be high in children but recent findings showing the presence of brown fat in adults, restored hope to use them as targets to treat obesity.

 

According to Vidal-Puig, obese people have less brown fat than lean people -- and the same applies for diabetics. &amp;quot;If you can increase the brown fat in obese and diabetic people then you can improve their situation,&amp;quot; says Vidal-Puig. This has been known for some time, but making it a reality has been a challenge.

The newly discovered sLR11 protein could provide the answer.


Removing the brakes


Vidal-Puig compares the protein to the brake of a car, stopping the body from accelerating its production of heat. &amp;quot;Obese people have more of these brakes, preventing them from creating heat and therefore losing fat,&amp;quot; says Vidal-Puig who has seen elevated levels of the protein in the blood of obese people included in his study. 

During the study, the team removed the gene producing this protein in mice and found they were able to burn calories faster. 

The researchers went on to examine the protein in humans and found that levels of the protein correlated with the total fat mass in a person. What's more, investigated levels in obese patients after they underwent bariatric surgery, and their weight loss was directly proportional to the decrease in levels of the sLR11 protein.

&amp;quot;[Brown fat cells] are an attractive therapeutic target for weight loss, and for anti-obesity or anti-type 2 Diabetes (T2D) therapies,&amp;quot; says Carole Sztalryd, Associate Professor of Medicine at the University of Maryland School of Medicine. Sztalryd's team also work on biological approaches to weight loss.


More brown than white on the cards


A common focus to tackle obesity has been on accelerating the production of brown fat cells so people burn more calories, but this new insight could achieve the same but through enhancing the activity -- and efficiency -- of cells. &amp;quot;We are stopping the brakes within the fat cells,&amp;quot; says Vidal-Puig, as the mice in his study became protected from obesity with increased browning of their white fat cells. 

The team believe controlling energy storage will be a better approach to beat the obesity epidemic than controlling people's eating habits.

But Sztalryd warns that additional studies are required to evaluate any clinical relevance,&amp;quot;New therapies are urgently needed for obesity. sLR11 seems promising but more work is needed to confirm if this is a relevant,&amp;quot; she says.

In the mean time, old tactics may be the answer and the more weight gained, the more exercise to be done.</gtr:impact><gtr:outcomeId>56d2c22d914d30.31386052</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://edition.cnn.com/2016/02/01/health/new-protein-fat-burn-feat/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mujer Hoy La dieta del Bien estar</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A183F7A9-1DEF-44FF-928B-AB9F648C7BDE</gtr:id><gtr:impact>http://www.mujerhoy.com/salud/dieta-bienestar-760227012014.html

&amp;quot;El mundo de la medicina en general, y en el de la nutrici&amp;oacute;n en particular, esta incorporando progresivamente la noci&amp;oacute;n del &amp;quot;microbioma&amp;quot;, no los genes humanos, sino las m&amp;uacute;ltiples especies microbianas que comparten con nosotros nuestro propio organismo&amp;quot;, se&amp;ntilde;ala el profesor Vidal Puig. &amp;quot;Estas bacterias, que superan en n&amp;uacute;mero nada menos que los 100 billones conforman un &amp;quot;superorganismo&amp;quot; que la ciencia apenas ha comenzado a cartografiar, pero cuyo papel a la hora de regular el metabolismo humano se revela cada vez m&amp;aacute;s trascendental&amp;quot;, asegura el experto. 

Trastornos en ese ecosistema, como la p&amp;eacute;rdida de diversidad de especies bacterianas y la proliferaci&amp;oacute;n de bacterias menos deseables, pueden predisponernos a la obesidad y a una larga lista de trastornos. Quiz&amp;aacute; ser&amp;iacute;a una buena idea aprender a convivir con ese superorganismo que tanto influye en nuestra salud, con una dieta y un estilo de vida m&amp;aacute;s saludables.</gtr:impact><gtr:outcomeId>56d2ce780159e4.40894409</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.mujerhoy.com/salud/dieta-bienestar-760227012014.html</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>newsweek thermogenesis</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DBA25FD5-3AF5-4C91-BA4C-FB974F61C7F2</gtr:id><gtr:impact>http://www.newsweek.com/2015/01/30/prepare-pill-make-you-thin-301250.html

In another area of Vidal-Puig's studies lies, potentially, an amazingly simple fix. In spite of all the millions spent on diets, food and exercise, it may be that something as basic as temperature is the answer. We all have two types of fat, white and brown. White fat is inert and sits in deposits. Brown fat, which regulates babies' temperatures but is much harder to pinpoint in adults, can be activated to burn calories and generate heat.

Studies show that exposure to low temperatures may encourage white fat to behave like brown fat. So while central heating ensures we move less and burn fewer calories, it's possible that lower temperatures might increase the activity of brown fat, which will burn our calories for us.</gtr:impact><gtr:outcomeId>56d2c9a85a6fe1.53975111</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.newsweek.com/2015/01/30/prepare-pill-make-you-thin-301250.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sofia, Bulgaria. 28th - 31st May 2014. European Congress on Obesity.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>83ADD1C3-F53B-493E-9C0D-6B78E3BBB2FD</gtr:id><gtr:impact>Sofia, Bulgaria. 28th - 31st May 2014. European Congress on Obesity. 
The congress featured the latest research on obesity from a wide range of fields including:

Discovery and Integrative Science 
Nutrition, Behaviour, Activity and Environment 
Childhood and Lifelong Perspectives 
Prevention, Public Health and Epidemiology 
Clinical Management and Translation 
Obesity as a Gateway to other Diseases 
Experts from around the world will present abstracts and deliver symposia on these themes. There will be a series of press conferences to showcase the items most of interest to the media, and press releases issued throughout the congress. A staffed media centre will be available on site to help journalists with their queries and interview requests</gtr:impact><gtr:outcomeId>56d301ad182ca5.26341599</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://easo.org/european-congress-on-obesity-2014-eco-2014/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> 5th - 9th June 2015. ADA Scientific Sessions Insulin Action/Molecular Metabolism.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E8EB7C3D-8E6F-4926-AA8D-DCAC47384480</gtr:id><gtr:impact>Lecture American Diabetes Association Conference 2015</gtr:impact><gtr:outcomeId>56d20235b047f1.81445764</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://professional2.diabetes.org/Presentations_Details.aspx?typ=10&amp;sr=adv&amp;cgr=238&amp;congress=238</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Wroclaw, Poland. 3rd - 7th May 2014. European Congress of Endocrinology.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>15FE5581-008C-4D12-A4DF-6339679CF511</gtr:id><gtr:impact>Here you will find all ECE 2014 information, including details of the pre-congress courses and include the oral communications that have been chosen following the abstract selection meeting in the scientific programme.

We look forward to welcoming you to Wroclaw for ECE 2014.

Paolo Beck-Peccoz
Joint Chair, Programme Organising Committee (POC)</gtr:impact><gtr:outcomeId>56d3031729ac18.88124500</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.ece2014.org/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Colorado, USA. 9th - 13th February 2015. Keystone Symposia - Systems Biology of Lipid Metabolism.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>25BE62E7-65B4-411B-A085-77D401726E8A</gtr:id><gtr:impact>Keystone Symposia organiser and speaker. 
Area Lipid Biochemistry</gtr:impact><gtr:outcomeId>56d202d312f7d6.10933276</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.keystonesymposia.org/15B4</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LR11 in Asia</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8F0B0361-7964-43E4-A1B9-B2ECBB634052</gtr:id><gtr:impact>LR11 news disseminated in Asia
???LR11/SorLA?????????????????????BMI???????????
Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans</gtr:impact><gtr:outcomeId>56d2ccf3d68ff7.04439773</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.natureasia.com/ja-jp/ncomms/abstracts/71218</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> European Neuroendocrinology Society meeting in Vienna. .</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BF09286A-1DA2-4053-AE69-DC1B148D8006</gtr:id><gtr:impact>Dr Sam Virtue recently presented at the prestigious European Neuroendocrinology Society meeting in Vienna. Sam's talk was focussed on metabolomics in endocrinology and was based on the past 9 years of experience in the TVP lab in the field of lipodomics. The purpose of the talk was to discuss how biologists without systems biology experience can work with groups specialising in the fields of metabolomics to design appropriate experiments and extract the maximum value from their data sets.

Dr Virtue has been invivted to give similar type of talk in other venues,</gtr:impact><gtr:outcomeId>cEoTNPvhiTA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Europe press</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DA056741-B589-40D5-BA84-C4F7C1840DBE</gtr:id><gtr:impact>This was an interview for Europe press news agency which has a huge diseminattion capacity. Some examples below.

http://www.europapress.es/chance/noticias.aspx?buscar=Antonio%2BVidal%2BPuig

http://www.europapress.es/chance/elbuenvivir/noticia-10-obesos-son-saludables-20111128124545.html

http://www.europapress.es/chance/noticias.aspx?buscar=Cambridge

http://www.enfermeriapalencia.com/modules.php?name=Noticias_enfermeras

Highewr visibility. Partients have contacted me through email with personal cases that have I have replayed so far but that if they continue to increase i may need to organise better through my web page. I am considering if i get resources to maintain in to include a page in my web for public questions and disemination.</gtr:impact><gtr:outcomeId>hrRKLJB14p6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.europapress.es/chance/noticias.aspx?buscar=Antonio%2BVidal%2BPuig</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Tokyo, Japan. 18th July 2013. Special lecture at Toho University Medical Center</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D994A4BF-43FE-48C5-B48C-E0950EEC098E</gtr:id><gtr:impact>Professor Toni Vidal-Puig visits the lab of Professor Hideaki Bujo at Toho University in Japan as part of their collaborative research programme on brown fat differentiation.</gtr:impact><gtr:outcomeId>56d30757ab6d51.32608463</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://tvp.mrl.ims.cam.ac.uk/events/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Congress on Obesity 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C8EE7A73-8B3B-4175-99B9-4FAA849671A7</gtr:id><gtr:impact>Vancouver, Canada. 1st - 4th May 2016. 13th International Congress on Obesity. 250 attendes</gtr:impact><gtr:outcomeId>58b980d4c96e13.37217305</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1F7F7E0F-CAFC-47D5-8B1D-A3D7BF47ADEA</gtr:id><gtr:impact>Blog from Sanger wich bord reach where we presented our research on brown fat

From clinical studies and animal models, scientists have noticed that some obese individuals can maintain a remarkable capacity to store fat before experiencing adverse metabolic effects associated with obesity, such as insulin resistance and Type 2 diabetes. It seems that the adipose tissue of these people has developed adaptive mechanisms that allow it to preserve its functionality while adjusting its biochemical features to maintain its biophysical characteristics. Read more here.

 Blog by</gtr:impact><gtr:outcomeId>5455116d840832.39891014</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Heidelberg, Germany. 12th May 2016. Seminar at German Cancer Research Center (DKFZ)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9101D259-C43B-414D-96DC-EADEBB1FC741</gtr:id><gtr:impact>Heidelberg, Germany. 12th May 2016. Seminar at German Cancer Research Center (DKFZ)</gtr:impact><gtr:outcomeId>58b981305fb9c4.50658075</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2CBE6248-871B-4DD2-A626-3A3CFD93B68D</gtr:id><gtr:impact>Blog from Sanger wich bord reach where we presented our research on brown fat

From clinical studies and animal models, scientists have noticed that some obese individuals can maintain a remarkable capacity to store fat before experiencing adverse metabolic effects associated with obesity, such as insulin resistance and Type 2 diabetes. It seems that the adipose tissue of these people has developed adaptive mechanisms that allow it to preserve its functionality while adjusting its biochemical features to maintain its biophysical characteristics. Read more here.

 Blog by</gtr:impact><gtr:outcomeId>54551178adc754.68257565</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>URJC Summer University Programme: Obesity, Insulin Resistance, and Metabolic Syndrome.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8718067C-2868-412B-A653-847D796F4675</gtr:id><gtr:impact>5. Madrid, Spain. 9th-11th July 2015. URJC Summer University Programme: Obesity, Insulin Resistance, and Metabolic Syndrome. 


Obesity, insulin resistance, diabetes and metabolic syndrome (C&amp;oacute;digo UV-S-OBESI) 

La inscripci&amp;oacute;n ha finalizado.





Ap&amp;uacute;ntate




 
Del 09-07-2015 al 11-07-2015
 
Sal&amp;oacute;n de Grados, Campus de Madrid, Facultad de Ciencias Jur&amp;iacute;dicas y Sociales, Paseo de los Artilleros s/n 
 
 
Organizado por Vicerrectorado de Extensi&amp;oacute;n Universitaria 
 
Tel&amp;eacute;fono de contacto: 914884762 
 Categor&amp;iacute;as:
Formaci&amp;oacute;n y docencia sanitaria

Investigaci&amp;oacute;n m&amp;eacute;dica

Medicina general
Palabras clave:
Diabetes and metabolic syndrom...

Insulin resistance

Obesity</gtr:impact><gtr:outcomeId>56d1fe868a52b6.92005308</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://uverano.urjc.es/event_detail/2355/programme/obesity-insulin-resistance-diabetes-and-metabolic-syndrome-codigo-uv-s-obesi.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SCIENCEALERT ON LR11</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A5D9BA7A-BD79-47FA-BD33-9C952E0EAA49</gtr:id><gtr:impact>Scientists have figured out how your body fights your attempts to lose weight 
Bummer.
DAVID NIELD 
11 DEC 2015 
For those of you who feel like your gym sessions aren't getting you anywhere near your target weight - scientists think they might have found a reason why. A new study has identified a protein that locks excess fat in our bodies, preventing it from being burned off easily. 

And while it sucks to know that our bodies are fighting against our attempts to lose weight, the discovery could help to explain why overweight people find it so difficult to shed the additional pounds.</gtr:impact><gtr:outcomeId>56d2c42aa78465.66143404</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.sciencealert.com/here-s-how-your-body-naturally-fights-your-attempts-to-lose-weight</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Members of the TVP lab recently attended the 1st ICAN conference series in Cardiometabolic Disease in Paris.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1FE15EBE-A707-4F5B-A2FB-E7F7AFBDDDEF</gtr:id><gtr:impact>TVP Lab members give presentations and posters at 1st ICAN conference series in Cardiometabolic Disease

Members of the TVP lab recently attended the 1st ICAN conference series in Cardiometabolic Disease in Paris. Vanessa Pellegrinelli was selected to give a presentation, and Camilla Ingvorsen, Guillaume Bidault, and Vivian Peirce were selected to present posters. Vivian Peirce was a joint-winner of Young Investigator poster award.



Projection of our lab</gtr:impact><gtr:outcomeId>5455123f7d4751.15222608</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Utah, USA. 17th - 22nd April 2015. Keystone Symposium - Beige and Brown Fat: Basic Biology and Novel Therapeutics.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>92A6B703-8689-4FFF-A6B6-7E9F0DCF53FC</gtr:id><gtr:impact>Beige and Brown Fat: Basic Biology and Novel Therapeutics (D5)
Organizer(s) Bruce M. Spiegelman and Sven Enerb&amp;auml;ck
April 17-22, 2015
Snowbird Resort ? Snowbird, Utah USA
The epidemic of obesity and diabetes has become a world-wide health risk. These metabolic disorders are a direct threat to the health and economic well-being of many nations. Unfortunately, education about diet and exercise are not sufficient to meet this emergency and new therapies are badly needed. Brown fat has emerged as one of the few genuinely new approaches to these problems. Brown fat exists in most or all adult humans and can dissipate caloric energy and improve both obesity and diabetes in experimental animals. This meeting will focus on new pathways controlling brown fat development and thermogenesis. We will delve into the types of brown fat cells, beige, classical brown and others. We will also put a special emphasis on emerging approaches, both biological and chemical, that can manipulate these cells for therapeutic purposes. It is our hope and belief that this meeting can nucleate expanded efforts in both academia and pharma to explore this promising research area. There has not been a Keystone Symposia conference dedicated to brown fat. While there has been a session here and there at the Obesity meeting, the science and the biomedical needs warrant this new and focused conference. Of course, this will also bridge the Obesity and Diabetes communities, and lead to pharma/academic collaborations.</gtr:impact><gtr:outcomeId>56d2bf20ae46b8.44402450</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.keystonesymposia.org/15D5</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>. London, UK. 11th January 2017. Seminar at the MRC Clinical Sciences Centre, Imperial College London.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C0622420-A914-4FD1-A226-FBFB9CA676F4</gtr:id><gtr:impact>. London, UK. 11th January 2017. Seminar at the MRC Clinical Sciences Centre, Imperial College London.</gtr:impact><gtr:outcomeId>58b98434549387.91569087</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stockholm, Sweden. 28th June - 2nd July 2014. International Society for the Study of Fatty Acids and Lipids.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>87450971-AE17-4417-95CB-9276CA2891CE</gtr:id><gtr:impact>http://www.issfal.org/conferences/2014-stockholm
Stockholm, Sweden. 28th June - 2nd July 2014. International Society for the Study of Fatty Acids and Lipids.
International conference focused on the role of fatty acids in disease</gtr:impact><gtr:outcomeId>56d2db99167b18.19295745</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.issfal.org/conferences/2014-stockholm</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Barcelona, Spain. 8th October 2016. CIBERDEM-MSD Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B0747522-E479-4F3E-B1D1-1E51543FBB16</gtr:id><gtr:impact>Barcelona, Spain. 8th October 2016. CIBERDEM-MSD Symposium</gtr:impact><gtr:outcomeId>58b983f02aed86.25470178</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Vancouver, Canada. 12th - 17th January 2014. Keystone Symposium on Obesity: A Multisystems Perspective.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>481A41C1-AA61-49A5-950A-33676D75E48B</gtr:id><gtr:impact>Obesity: A Multisystems Perspective (J2)


Organizer(s) Roger D. Cone, Barbara Cannon and Lee M. Kaplan

January 12-17, 2014

Fairmont Hotel Vancouver ? Vancouver, British Columbia Canada

Discounted Abstract Deadline: Oct 4, 2013

Abstract Deadline: Oct 29, 2013

Scholarship Deadline: Oct 4, 2013

Discounted Registration Deadline: Nov 14, 2013


Supported by the Directors' Fund


Joint Meeting: Challenges and Opportunities in Diabetes Research and Treatment (J1) 


Summary of Meeting:
This meeting will cover the latest discoveries on the role of multiple organ systems in the process of energy homeostasis and obesity. In addition to the role of the central nervous system and white adipose tissue (WAT) depots, this meeting will examine the role of WAT development, brown fat, the microbiome, gut-brain signaling and circadian rhythms in the development of obesity. Bariatric surgery and the latest pharmaceutical approaches to obesity treatment will also be considered, as will the latest genetic approaches to both common and rare syndromic obesity. Joint sessions with the Keystone Symposia meeting on Challenges and Opportunities in Diabetes Research and Treatment will include &amp;quot;The Role of Brown Adipose Tissue in Thermogenesis and Glucose Uptake&amp;quot; and &amp;quot;Mechanisms Underlying the Efficacy of Bariatric Surgery.&amp;quot; This meeting will bring together a diverse array of leading scientists from the U.S., Europe and Japan to talk about breaking discoveries in a very broad array of physiological processes relevant to obesity and its treatment. The goal of the meeting will be to provide participants with an update on cutting-edge developments in the field, as well as with a broader perspective on the biology of obesity. The anticipated outcome is the development of new, and potentially interdisciplinary, research collaborations and directions.</gtr:impact><gtr:outcomeId>56d303b90e06a6.94556406</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.keystonesymposia.org/14J2</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D27B82FB-CF90-4FD2-8A29-4A12D6977124</gtr:id><gtr:impact>Fighting fat with fat
Obesity is one of the most important biomedical problems in our society and also one of the most frustrating to tackle. For this reason, the recent identification of functional brown fat in adult humans has made the obesity research community very excited. Read more here.

Sanger Institute Blog by Dr Stefania Carobbio

Projection of our lab</gtr:impact><gtr:outcomeId>545512fa01cf99.81543785</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk/events/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> London, UK. 24th April 2015. Royal Society of Medicine Symposium. Obesity: Epidemiology, complications and management.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EB25DAA9-6A76-4E8E-8655-F902FB55FECA</gtr:id><gtr:impact>This symposium provided a multidisciplinary forum for researchers and healthcare workers to discuss the most recent advances, trends and management challenges encountered in the field of obesity.

Throughout the day, delegates explored the opportunities and challenges faced by those involved in obesity medicine, together with the solutions that have currently been adopted.

The symposium aimed at all those working in the field or with an interest in obesity medicine, vascular risk medicine, PhD students, post-doctoral researchers, and clinicians of all medical specialties including medical students, foundation and core trainees, general practitioners, physicians and surgeons.</gtr:impact><gtr:outcomeId>56d1ff619a0be9.23495772</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.rsm.ac.uk/events/events-listing/2014-2015/sections/lipids,-metabolism-vascular-risk-section/lif02-obesity-epidemiology,-complications-and-management.aspx</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Vienna, Austria. 15th-19th October 2016.  UEG Week.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4A2F4AB0-2313-47EF-9894-B8AA4F9643B3</gtr:id><gtr:impact>2. Vienna, Austria. 15th-19th October 2016. UEG Week. Main meeting on gastroenterology in Europe.</gtr:impact><gtr:outcomeId>58b98259303547.44144760</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Heidelberg, Germany. 16th - 17th October 2015. International Symposium On Diabetic Complications</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>08F26EAA-D551-4FEB-A789-E2B5A1E6D978</gtr:id><gtr:impact>Heidelberg, Germany. 16th - 17th October 2015. International Symposium On Diabetic Complications
Event Description

HIDC 2015, 2th Heidelberg International Symposium on Diabetic Complications is going to be placed in between 16 October, 2015 and 17 October, 2015. 

The Symposium place is going to be Heidelberg University Hospital. 

HIDC 2015 is likely to be a stage where many notable themes are likely to be discoursed. Several of these are going to be Biology, Metabolic Diseases, Diabetes, Diabetes Research, Medical and Health Care. 

2th Heidelberg International Symposium on Diabetic Complications is organized annually.</gtr:impact><gtr:outcomeId>56d203f1585c30.18883374</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.klinikum.uni-heidelberg.de/Welcome.138789.0.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keystone Symposia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>700A1F4A-4A5B-4C99-A4AF-0057A18B730A</gtr:id><gtr:impact>Keystone Symposia - Nuclear Receptors and Friends: Roles in Energy Homeostasis and Metabolic Dysfunction. Alpbach, Austria, 3rd-8th April 2113.

 Keystone Symposia - Systems Biologyof Lipid Metabolism (9th - 13th February 2015)
Colorado, USAOrganisers: Matej Ore?ic, Antonio Vidal-Puig, Ana Maria Cuervo

Increased applicants to the lab</gtr:impact><gtr:outcomeId>Be14rP8cAoC</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&amp;meetingid=1235</gtr:url><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ADA 2016.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7194E08D-322A-451C-87FC-792C1FC8384C</gtr:id><gtr:impact>New Orleans, USA. 10th - 14th June 2016. American Diabetes Association's Scientific Session's 76th Scientific Sessions.</gtr:impact><gtr:outcomeId>58b98180728ea5.03435349</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Suzhou, China. 1st - 5th June 2015. Cold Spring Harbor Asia (CSHA) Conference on Lipid Metabolism and Metabolic Disorders</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BD72C372-A469-4171-8C65-1AA143DBD628</gtr:id><gtr:impact>The conference will include eight oral sessions and one poster session covering the latest findings across many topics in lipid metabolic. Many talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference provide ample opportunity for informal interactions.

 Alterations in lipid homeostasis play critical roles in the development of human metabolic disorders, such as obesity, type II diabetes and fatty liver. This meeting brings together world-leading experts to present and discuss latest developments in the study of lipid metabolism, as well as their implications for human health and disease. The conference will include eight oral sessions and one poster session. Additional oral presentations will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference will provide ample opportunities for scientific as well as informal interactions</gtr:impact><gtr:outcomeId>56d204766e9e13.05546558</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.csh-asia.org/2015meetings/Metabo.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Award Lecture in Boston, USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>68EEB192-E854-4B45-A773-C93651B88E6E</gtr:id><gtr:impact>22nd Pat Usher Memorial Award Lecture, Harvard Medical School, Boston, USA. 18th January 2013.

-</gtr:impact><gtr:outcomeId>EPdryyA9KgH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Symposium: Latest in obesity Madrid, Spain. 1st - 2nd December 2015.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A6876398-54D5-4A76-BF60-D2257FD1BA9F</gtr:id><gtr:impact>http://www.fundacionareces.es/fundacionareces/cargarAplicacionAgendaEventos.do?idTipoEvento=1&amp;amp;identificador=1827?elAgenda=2
Along with obesity, diabetes is a true pandemic of the 21st century which carries a certain risk of other diseases such as cardiovascular diseases, or even cancer. It is purpose of this symposium to bring to our attention and knowledge the most recent advances on the disease and we hope to do so thanks to the remarkable roster of personalities who have accepted our invitation to share their knowledge and ideas in this INTERNATIONAL SCIENTIFIC SYMPOSIUM: LATEST IN OBESITY sponsored by the Fundaci&amp;oacute;n Ram&amp;oacute;n Areces and with the collaboration of the Fundaci&amp;oacute;n General CSIC.</gtr:impact><gtr:outcomeId>56d1fae2625e02.76678003</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.fundacionareces.es/fundacionareces/cargarAplicacionAgendaEventos.do?idTipoEvento=1&amp;identificador=1827&amp;nivelAgenda=2</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Adipose tissue expandaqbility-EL COMERCIO ASTURIAS</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>654BCB84-41E8-47DD-8548-A661D9BF8590</gtr:id><gtr:impact>&amp;lt;&amp;gt;
Antonio Vidal-Puig, catedr&amp;aacute;tico en Cambridge y director adjunto del Centro de Obesidad y Enfermedades Asociadas. Premio Internacional Hip&amp;oacute;crates 2015
&amp;lt;&amp;gt;</gtr:impact><gtr:outcomeId>56d2cbc1d79f77.95470925</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.elcomercio.es/asturias/201511/27/puede-obeso-saludable-siempre-20151127002423-v.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>11/11/2014- www.teinteresa.es, Madrid Brown fat</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>498B12FC-3509-4F29-816F-A09253BC09E4</gtr:id><gtr:impact>La grasa marr&amp;oacute;n, clave en la lucha contra la obesidad
1456655859 
11/11/2014- www.teinteresa.es, Madrid 

Las compa&amp;ntilde;&amp;iacute;as farmac&amp;eacute;uticas est&amp;aacute;n invirtiendo en la investigaci&amp;oacute;n para desarrollar un m&amp;eacute;todo para convertir la grasa blanca en grasa marr&amp;oacute;n.
Modificaciones de la flora bacteriana han podido ayudar a reducir la obesidad en animales, y podr&amp;iacute;a aportar soluciones a la obesidad humana</gtr:impact><gtr:outcomeId>56d2cff56a99b4.91235578</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.teinteresa.es/salud/grasa-marron-clave-lucha-obesidad_0_1246676023.html</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> 36 Congreso Sociedad Espa?ola de Farmacolog?a.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6C5E2752-EDAF-4491-AB50-E86AFD0799C9</gtr:id><gtr:impact>http://congresosef2015.com/programa-cientifico/esquema-del-programa/
12:30 - 13:30 
Sesi&amp;oacute;n Plenaria.

Moderadora: Dra. M&amp;ordf; Jes&amp;uacute;s Sanz Ferrando
Universitat de Val&amp;egrave;ncia.
Adipose tissue expandability, lipotoxicity and the metabolic syndrome.
Prof. Antonio Vidal Puig University of Cambridge. Reino Unido.</gtr:impact><gtr:outcomeId>56d1fdb11c4049.44974893</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://congresosef2015.com/programa-cientifico/esquema-del-programa/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>San Francisco, USA. 13th-17th June 2014. ADA's 74th Scientific Sessions.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BD86D252-3D36-4F8A-8B74-AC20C477378A</gtr:id><gtr:impact>San Francisco, USA. 13th-17th June 2014. ADA's 74th Scientific Sessions. 
International conference in Diabetes</gtr:impact><gtr:outcomeId>56d2dc45b0f137.89754565</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.medscape.com/viewarticle/827131</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TECHTIMES</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3FD38A91-9557-4E8E-AE53-F62D7B2867A6</gtr:id><gtr:impact>Being Fat Makes It Harder To Lose Weight: Fatter People Produce More Protein That Inhibits Depletion Of Fat Cells
Fat people have a more difficult time of losing weight because of the increased production of a protein called sLR11. This inhibits the body's ability to burn calories and fats for heat production</gtr:impact><gtr:outcomeId>56d2c5952bd1a9.82536139</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.techtimes.com/articles/110892/20151127/being-fat-makes-it-harder-to-lose-weight-fatter-people-produce-more-protein-that-inhibits-depletion-of-fat-cells.htm</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GACETA MEDICA-Lilly</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>59D3DF47-9631-4AE6-A96C-F395C640C884</gtr:id><gtr:impact>Gaceta M&amp;eacute;dica 
Domingo, 28 de Febrero de 2016
Felipe Casanueva Freijo, presidente de la Sociedad Espa&amp;ntilde;ola para el Estudio de la Obesidad, y Manuel Puig-Domingo, presidente de la Sociedad Espa&amp;ntilde;ola de Endocrinolog&amp;iacute;a y Nutrici&amp;oacute;n, entregaron al profesor Antonio Vidal Puig el &amp;quot;Premio Fundaci&amp;oacute;n Lilly a una Carrera Distinguida 2015&amp;quot; en la especialidad de Endocrinolog&amp;iacute;a, Nutrici&amp;oacute;n y Obesidad por su contribuci&amp;oacute;n al conocimiento del tejido adiposo y el abordaje y prevenci&amp;oacute;n de la obesidad. Este galard&amp;oacute;n fue otorgado en el marco del Simposio Internacional 'Lo &amp;uacute;ltimo en Obesidad'</gtr:impact><gtr:outcomeId>56d2ca9f6e8ed2.16484454</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.gacetamedica.com/noticias-medicina/2015-12-04/en-10-minutos/premio-a-la-trayectoria-en-endocrinologia/pagina.aspx?idart=952960</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>La obesidad est? en el cerebro&quot; Lilly Areces</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>939777B6-3099-4B35-B2A2-630EC8867460</gtr:id><gtr:impact>M&amp;aacute;s de 500 millones de personas en el mundo padecen obesidad. 
Un simposio organizado por la Fundaci&amp;oacute;n Ram&amp;oacute;n Areces y la Fundaci&amp;oacute;n General del CSIC analiza las &amp;uacute;ltimas investigaciones sobre este problema de salud p&amp;uacute;blica.</gtr:impact><gtr:outcomeId>56d2c8946fe106.21586510</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://hipertextual.com/2015/12/obesidad#</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Alabama, USA. 19th November 2013. University of Alabama at Birmingham, Nutrition Obesity Research Center - NORC's Noon Seminar Series.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>95BECF88-2EED-42BB-9F7B-5C9AD45A4F1D</gtr:id><gtr:impact>The seminar is sponsored by the Nutrition Obesity Research Center and co-sponsored by the Department of Nutrition Sciences.
Addressed the problem of adipose tissue expandability and metabolic syndrome</gtr:impact><gtr:outcomeId>56d3058e776c31.55450586</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.norc.uab.edu/courses/seminars/seminar2013#</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E3772C65-A771-4FAB-B1A3-4395B1720288</gtr:id><gtr:impact>Blog from Sanger wich bord reach where we presented our research on brown fat

From clinical studies and animal models, scientists have noticed that some obese individuals can maintain a remarkable capacity to store fat before experiencing adverse metabolic effects associated with obesity, such as insulin resistance and Type 2 diabetes. It seems that the adipose tissue of these people has developed adaptive mechanisms that allow it to preserve its functionality while adjusting its biochemical features to maintain its biophysical characteristics. Read more here.

 Blog by Dr Stefania Carobbio</gtr:impact><gtr:outcomeId>5455116a685de3.90097308</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.tvp.mrl.ims.cam.ac.uk</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>Singapore, Republic of</gtr:country><gtr:currCode>SGD</gtr:currCode><gtr:currCountryCode>Singapore</gtr:currCountryCode><gtr:currLang>en_SG</gtr:currLang><gtr:description>Cambridge-NUHS Seed Fund</gtr:description><gtr:fundingOrg>National University Health System (NUHS)</gtr:fundingOrg><gtr:fundingRef>Study of FIT FAT</gtr:fundingRef><gtr:id>CA956C45-6F12-4588-9AF8-DD92629D816E</gtr:id><gtr:outcomeId>gAP3JgpchyL</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>980000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Programme Grant no. . &amp;quot;Adipose tissue macrophage polarisation and lipotoxicity&amp;quot;. 2013-2017. &amp;pound;933,182.00</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>58D01B13-6EC9-4396-A3CD-6D989BC951BE</gtr:id><gtr:outcomeId>cxFq1AaYDBD</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7 - IMI EMIF Joint Undertaking. PI: Dr Vidal-Puig. &amp;pound;300,000.</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>80D70E97-59EA-4259-AA04-656E33B00735</gtr:id><gtr:outcomeId>5454f3543a8d57.34330615</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Horizon 2020</gtr:department><gtr:description>2020 Horizon Epoos</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>862751DC-3BF5-47F2-9FA1-68A92332F08E</gtr:id><gtr:outcomeId>56d1f5d988e428.90878329</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Horizon 2020</gtr:department><gtr:description>ERC Senior award</gtr:description><gtr:end>2020-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>A7342B0F-F41C-41F4-B8BB-80B3C3FAEE70</gtr:id><gtr:outcomeId>56d1f52af17f12.01299517</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>13000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Evelyn Fund</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Addenbrooke's Charitable Trust (ACT)</gtr:fundingOrg><gtr:id>9F45B313-B6DC-432E-85EE-AB9E9DECBAB1</gtr:id><gtr:outcomeId>5454f442efea14.05380159</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SAB scientific Advisory boards</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>1CD628C6-27C7-4177-8361-B6DCD4456562</gtr:id><gtr:impact>Evidence of international standing

? MRC College of experts (1/10/2004-30/09/2008).
? MRC Physiological Systems and Clinical Sciences Board (1/10/2004-30/09/08).
? MRC Funding Schemes: Survey panel (2003-2004).
? International scientific advisor Spanish Research Council, Metabolism and Nutrition Node (2003-2008). 
? Member of the Editorial Board of PLoS Biology, Diabetes, Biochemical Journal and Trends Endocrinology and Metabolism.
? Member of PLoS Biology Advisory Board (2010-)
? EAS 2010 Scientific Committee
? EAS Election Committee Member
? Member of the Diabetes UK Research Committee 
? International Scientific Committee of CIBERDEM
? FP7 FLORINASH Scientific Advisory Board
? Committee for Severo Ochoa Research Excellence Awards of Spanish Ministry of Innovation.
? IDIBAPS Scientific Advisory Board (2012-)
? EASO Scientific Advisory Board (2013-)
? Member of Wellcome Trust Strategic Award [Biological determinants of ageing and late life health, and their pharmacological manipulation] Scientific Advisory Board (2013-)-)
? Scientific Advisory Board of Institut d'Investigacions Biom&amp;egrave;diques de Girona (IDIBGI) (2013-)</gtr:impact><gtr:outcomeId>56d2d2eb429677.85556376</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://tvp.mrl.ims.cam.ac.uk/events/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Editorial Activity</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>CDB90C37-BCD2-4F64-A72C-5A48ABF8BB49</gtr:id><gtr:impact>? Editorial Advisory Board: PLoS Biol (2009-)
? Editorial Board Memberships: PLoS Biology (2007-), Biochemical Journal (2008-2012), Diabetes (2012-) Trends Endocrinology and Metabolism (2008-), Biochim Biophys Acta.(2012-).Guest Editor (with RH Unger) of Special issue on lipotoxicity. Biochim Biophys Acta. 2010 Mar;1801(3):207-8.</gtr:impact><gtr:outcomeId>56d2d3716e3687.75325138</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EASO Advisory Board Meeting</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D8BCD513-D504-4B9B-8F10-8F3311402CE5</gtr:id><gtr:impact>Redefinition of obesity on the basis of body composition. BMI considered obsolete.</gtr:impact><gtr:outcomeId>PLjvh814C2x</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Organisation of conferences/Courses</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>A83E2A08-134F-4C4F-91E0-032395A8BAA6</gtr:id><gtr:impact>It is expected these training schemes have contributed to better care and scientifc developments.

Member of the Scientific Organising Committee

1. Cambridge, United Kingdom. 30th June - 2nd July 2015. EAS Advanced Course in Cardiometabolic Phenotyping in Rodents.
2. Boston, USA. 5th - 9th June 2015. ADA Scientific Sessions Insulin Action/Molecular Metabolism.
3. Colorado, USA. 9th - 13th February 2015. Keystone Symposia - Systems Biology of Lipid Metabolism. 
4. Madrid, Spain. 7th - 8th November 2014. CNIC Conference &amp;quot;Energy homeostasis and metabolic disease&amp;quot;. 
5. Madrid, Spain. 7th-8th November 2014. Energy homeostasis and metabolic disease. CNIC.
6. Cambridge, UK. 30th September 2014. 14th Annual Cambridge Immunology Forum Meeting. 


? Member of the Scientific Organising Committee Keystone meeting on Nuclear receptors. (http://www.keystonesymposia.org/Meetings/viewMeetings.cfm?MeetingID=1235?Tab=travel) Austria (2013)
? Member of the Scientific Organising Committee 15th European Congress of Endocrinology 27th April - 1st May 2013. Copenhagen, Denmark (http://www.ece2013.org/committees.aspx)
? Director of The European Atherosclerosis Society Advanced Course IV: Murine Genetics and Cardiometabolic Phenotyping 11th - 14th July 2012. Cambridge, United Kingdom (http://www.eas-society.org/advanced-course-iv,-cambridge.aspx
? Member of the Organising Scientific Committee of The Royal Society and Academy of Medical Sciences symposium on &amp;quot;Brown adipose tissue: a new human organ?&amp;quot; London (2012) (http://www.physoc.org/me2012) 
? Member of the Organising Scientific Committee The Obese Species Workshop Sicily, Italy. 21st - 26th October (2011) http://theobesespecies.unipr.it/.
? Member of the Organising Scientific Committee for the meeting of the EAS in Hamburg. Germany (2010)
? Member of the Organising Scientific Committee of the 49th International Conference on the Bioscience of Lipids. Maastrich (2008)</gtr:impact><gtr:outcomeId>scYTFVx5j3f</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Development of tools for lipid analysis and integration with gene expressison analysis using multivariant analysis</gtr:description><gtr:id>2DD7EC91-278E-4754-BFD0-168C8FBFCC61</gtr:id><gtr:impact>Fundamental for papers including lipidomic analysis which is central to our programme</gtr:impact><gtr:outcomeId>54550606a9cad1.21755612</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Technology  for lipidomic data analysis</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>This is a novel technology to evaluate maximal capacity of energy expenditure and is the best method to evaluate defects in energy expenditure leading to obesity.</gtr:description><gtr:id>D02DAE29-4729-4F2C-AA6F-DC27658838C3</gtr:id><gtr:impact>Contributed to make research results reproducible and also contributes to 3R,</gtr:impact><gtr:outcomeId>58b9864f55ffe1.88888625</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Modelst for maximal termogenic capacity evaluation</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A more accurate and refined methodology to assess tissue specific insulin resistance</gtr:description><gtr:id>38A62576-D354-4AB9-A693-B59932AFC9FA</gtr:id><gtr:impact>Schreiber R, Hofer P, Taschler U, Voshol PJ, Rechberger GN, Kotzbeck P, Jaeger D, Preiss-Landl K, Lord CC, Brown JM, Haemmerle G, Zimmermann R, Vidal-Puig A, Zechner R.
Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity.
Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13850-5. doi: 10.1073/pnas.1516004112. Epub 2015 Oct 27.
PMID: 26508640 Free PMC Article


Smith MA, Katsouri L, Irvine EE, Hankir MK, Pedroni SM, Voshol PJ, Gordon MW, Choudhury AI, Woods A, Vidal-Puig A, Carling D, Withers DJ.Ribosomal S6K1 in POMC and AgRP Neurons Regulates Glucose Homeostasis but Not Feeding Behavior in Mice.Cell Rep. 2015 Apr 21;11(3):335-43. doi: 10.1016/j.celrep.2015.03.029. Epub 2015 Apr 9.
PMID: 25865886 Free PMC Article</gtr:impact><gtr:outcomeId>56d2d6c299ff79.76596171</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Hyperinsulinaemic clamps using non stable isotopes</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development of three core facilities, a) Murine phenotyping, b) Murine Biochemistry and c) Murine Histopathology</gtr:description><gtr:id>8ACB283B-37DD-439C-9B93-C278564BDF4C</gtr:id><gtr:impact>Development of MRC CORD murine metabolic programme
Development and expansion vreating the Cambridge Phenomics centre.</gtr:impact><gtr:outcomeId>D218E862BCE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Development of the Phenomics center</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>LEM-PCR: a method for determining relative transcript isoform proportions using real-time PCR without a standard curve.Virtue S, Dale M, Sethi JK, Vidal-Puig A.
Genome. 2010 Aug;53(8):637-42.</gtr:description><gtr:id>68DF84C5-2359-4227-88AA-2D7C099AD86A</gtr:id><gtr:impact>Improved accuracy of data analysis</gtr:impact><gtr:outcomeId>qQxNc6Q64uw</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Tools for data quatification</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Protocol tomeasure maximal thermogenic capacity</gtr:description><gtr:id>2F05A4E8-CF1E-43C9-8623-9EA0B18D5250</gtr:id><gtr:impact>Contribution to increase accuracy of murine sudies allowing refinment, and reduction of animals</gtr:impact><gtr:outcomeId>545502c0a83511.05828747</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Phenotyping of mice; Maximal thermogenic activity</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have contributed to develop methods for lipid analysis</gtr:description><gtr:id>814D1A2F-328F-472C-8B85-158959C0B881</gtr:id><gtr:impact>1) Oresic M, H?nninen VA, Vidal-Puig A.Lipidomics: a new window to biomedical frontiers.Trends Biotechnol. 2008 Dec;26(12):647-52. Epub 2008 Oct 23PMID: 18951641 2)Tang J, Tan CY, Oresic M, Vidal-Puig A. Integrating post-genomic approaches as a strategy to advance our understanding of health and disease. Genome Med. 2009 Mar 30;1(3):35. [Epub ahead of print] PMID: 19341506 3) Yetukuri L, Ekroos K, Vidal-Puig A, Oresic M. Informatics and computational strategies for the study of lipids.Mol Biosyst. 2008 Feb;4(2):121-7. Epub 2007 Dec 18. Review. 4).Oresic M, Vidal-Puig A, H?nninen V.Metabolomic approaches to phenotype characterization and applications to complex diseases.Expert Rev Mol Diagn. 2006 Jul;6(4):575-85. Review.</gtr:impact><gtr:outcomeId>4BBCE927162</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Development of methodology for microarray and lipidomic analysis</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://europepmc.org/abstract/MED/18951641</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Microarray and lipidomic data form in vivo experiments using animal models</gtr:description><gtr:id>153A4388-5B34-4E96-A3A1-633B0DEABD26</gtr:id><gtr:impact>This material has been utilised by other EU groups focused in modelling and development of tools for nutritional research</gtr:impact><gtr:outcomeId>8668068A9B9</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Microarray/lipidomic  data bases</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>In collaboration with Ideas Studio, we have designed new metabolic cages (SMS cages) that monitor movement, food preference and consumption, water consumption. This caging system is set for calorimetry and has its own lighting and a camera attached so the animals can be checked without having to enter the room. This equipment represents a refinement compared to the previously used CLAM system from Columbus.</gtr:description><gtr:id>4A951FE0-9E68-4FC9-8AED-2524E99287F5</gtr:id><gtr:impact>This caging system is set for calorimetry and has its own lighting and a camera attached so the animals can be checked without having to enter the room. This equipment represents a refinement compared to the previously used CLAM system from Columbus.</gtr:impact><gtr:outcomeId>ZadHsfSWDq5</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>metabolic Cages</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development of Flow cytometry to study adipose tissue macrophages</gtr:description><gtr:id>2A4EA619-5CFA-4FC6-82B3-9472849E8183</gtr:id><gtr:impact>Improvement and refinement allowing decreasing the number of animals required</gtr:impact><gtr:outcomeId>545503b417c320.06830565</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Citometry</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Refined technology to measure lipid composition.</gtr:description><gtr:id>CDFE8EB8-D820-4BBB-9591-9DFB2D821B7C</gtr:id><gtr:impact>1. Yew Tan C, Virtue S, Murfitt S, Robert LD, Phua YH, Dale M, Griffin JL, Tinahones F, Scherer PE, Vidal-Puig A. Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance. Sci Rep. 2015 Dec 17;5:18366. doi: 10.1038/srep18366.

2. Tan CY, Virtue S, Bidault G, Dale M, Hagen R, Griffin JL, Vidal-Puig A. Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6. Cell Rep. 2015 Dec 15;13(10):2039-47. doi: 10.1016/j.celrep.2015.11.004. Epub 2015 Nov 25.

3. Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, Vidal-Puig A, Teleman AA. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature. 2015 Jul 27. doi: 10.1038/nature14601.</gtr:impact><gtr:outcomeId>56d2d75a191f68.55613644</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mass Spectrometry to analyse lipids</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This is a new cageingsystem for metabolicphenotyping for simultaneous assessment of food inatke, energy expnditure, activity, water consumption. The equipment incorporates novel features such as having food delivery system hook to the cover of the cage. Also this is system is adapted to the cages where are normally hold which prevents measurement artifacts derived from changes in the cages when performing metabolic measurements. The new developed system to assess energy balance is a refinement because we can measure more accurately in each experiment. The addition of a 24h camera system with Visual Sonics software enables us to have secure systems to observe without disturbing measurements.</gtr:description><gtr:id>0ACDE3C0-BE85-4A8A-8AB7-ADEED681D744</gtr:id><gtr:impact>Reduction and refinement of experiments using murine models</gtr:impact><gtr:outcomeId>jpW8yAxq5Wq</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>b)	Design a unique in house system for energy balance measurement.</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Protocols do differentiation of Human PSC to brown, white and macrophage phenotype</gtr:description><gtr:id>EDCB57C5-5746-4A29-BAFB-6D272242FA9D</gtr:id><gtr:impact>Competitiveness in our research and funding acquisition e.g. ERC grant</gtr:impact><gtr:outcomeId>58b98562619a65.89624617</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Differentiation of ES cells</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B17E5A22-7DE7-4FE7-A6F3-E9391F4996B4</gtr:id><gtr:title>Peroxisome proliferator-activated receptor gamma-coactivator-1 alpha coordinates sphingolipid metabolism, lipid raft composition and myelin protein synthesis.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d21ef145a296458fa113ac78eb247493"><gtr:id>d21ef145a296458fa113ac78eb247493</gtr:id><gtr:otherNames>Camacho A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>pm_16153_23_23763823</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2F846F3-8C49-47DD-B48F-C2955074FF90</gtr:id><gtr:title>Prostaglandin profiling reveals a role for haematopoietic prostaglandin D synthase in adipose tissue macrophage polarisation in mice and humans.</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e137cbde914442352a009c77419799ba"><gtr:id>e137cbde914442352a009c77419799ba</gtr:id><gtr:otherNames>Virtue S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn><gtr:outcomeId>56cdf4dd0461b3.29863385</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FED235B-1C7A-4A01-B6B1-4F328E6E2BFC</gtr:id><gtr:title>Extracellular Vesicles: Novel Mediators of Cell Communication In Metabolic Disease.</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/120893d6db842ae2fac96265727b0fb4"><gtr:id>120893d6db842ae2fac96265727b0fb4</gtr:id><gtr:otherNames>Huang-Doran I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn><gtr:outcomeId>58b96da8d8c014.87269105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>054DF028-C96B-4DD9-ABC8-5B15D8BE88F9</gtr:id><gtr:title>Transducin-like enhancer of split 3 (TLE3) in adipose tissue is increased in situations characterized by decreased PPAR? gene expression.</gtr:title><gtr:parentPublicationTitle>Journal of molecular medicine (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b358298cf9c13221b098972badf64ad"><gtr:id>0b358298cf9c13221b098972badf64ad</gtr:id><gtr:otherNames>Ortega FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0946-2716</gtr:issn><gtr:outcomeId>5454ab4feaab97.37087593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93A2D23C-3440-4394-84A2-4042864A5FF7</gtr:id><gtr:title>When BAT is lacking, WAT steps up.</gtr:title><gtr:parentPublicationTitle>Cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4812c617c0423911393576c4924e270b"><gtr:id>4812c617c0423911393576c4924e270b</gtr:id><gtr:otherNames>Whittle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1001-0602</gtr:issn><gtr:outcomeId>pm_16153_23_23609798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0ED89072-0B60-464C-AE9A-E26B3A5C37E6</gtr:id><gtr:title>Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3098d46384b300a0dd4b590e33f76cd"><gtr:id>f3098d46384b300a0dd4b590e33f76cd</gtr:id><gtr:otherNames>Carobbio S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>pm_16153_23_23919961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78C8F495-E708-4C65-A554-5AD23A8C13BD</gtr:id><gtr:title>Harnessing the beneficial properties of adipogenic microbes for improving human health.</gtr:title><gtr:parentPublicationTitle>Obesity reviews : an official journal of the International Association for the Study of Obesity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21826ce4a9b86887430ca5d27dfdefe6"><gtr:id>21826ce4a9b86887430ca5d27dfdefe6</gtr:id><gtr:otherNames>Dhurandhar NV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1467-7881</gtr:issn><gtr:outcomeId>pm_16153_23_23663746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>171DB451-6157-4C84-80F7-09D683593F39</gtr:id><gtr:title>Psychosocial stress induces hyperphagia and exacerbates diet-induced insulin resistance and the manifestations of the Metabolic Syndrome.</gtr:title><gtr:parentPublicationTitle>Psychoneuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8d8fda57a38e9b1a74544b26fc498bd"><gtr:id>f8d8fda57a38e9b1a74544b26fc498bd</gtr:id><gtr:otherNames>Sanghez V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0306-4530</gtr:issn><gtr:outcomeId>pm_16153_23_24060458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BD7662E-E5FE-49AB-A208-933AB3943B8B</gtr:id><gtr:title>'Basic and Applied Thermogenesis Research' Bridging the Gap.</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3098d46384b300a0dd4b590e33f76cd"><gtr:id>f3098d46384b300a0dd4b590e33f76cd</gtr:id><gtr:otherNames>Carobbio S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn><gtr:outcomeId>5aa422cfc53174.13753443</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>098EA071-909C-4187-8793-047BE993E2D1</gtr:id><gtr:title>Dietary (Poly)phenols, Brown Adipose Tissue Activation, and Energy Expenditure: A Narrative Review.</gtr:title><gtr:parentPublicationTitle>Advances in nutrition (Bethesda, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da7972d12b05162651eb0d2672d0701c"><gtr:id>da7972d12b05162651eb0d2672d0701c</gtr:id><gtr:otherNames>Mele L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2161-8313</gtr:issn><gtr:outcomeId>5aa422d16aa437.11057347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF4D90C5-D554-423C-8AB4-C95B02BD21D5</gtr:id><gtr:title>Response to letter regarding article, &amp;quot;Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/acea86a51f490daeab90416072f26605"><gtr:id>acea86a51f490daeab90416072f26605</gtr:id><gtr:otherNames>Yu E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>5454ab504a8640.62041925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>534B3483-8359-4FD3-856A-64EB77B79128</gtr:id><gtr:title>A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c76c446e6a2d372e762aff1c0ce3437"><gtr:id>9c76c446e6a2d372e762aff1c0ce3437</gtr:id><gtr:otherNames>Moreno-Navarrete JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>pm_16153_23_23963324</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>616C8F8C-79DA-4E9E-8CF8-47AA9D49AD73</gtr:id><gtr:title>A Selective Sweep on a Deleterious Mutation in CPT1A in Arctic Populations.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38135e190aec3687cd14ecc949cbbae4"><gtr:id>38135e190aec3687cd14ecc949cbbae4</gtr:id><gtr:otherNames>Clemente FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>56cdf4dda10ce6.50407351</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>010D3E62-3A01-4208-92FD-4387AFA3ED1D</gtr:id><gtr:title>Deriving functional beige fat from capillaries.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2f6fa35b5d82a323e0c15bcb6bdef6d"><gtr:id>a2f6fa35b5d82a323e0c15bcb6bdef6d</gtr:id><gtr:otherNames>Pellegrinelli V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>56dc073535cb61.55429294</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>795512C0-D251-444A-A6BC-82CC67652BA7</gtr:id><gtr:title>Cdkn1c Boosts the Development of Brown Adipose Tissue in a Murine Model of Silver Russell Syndrome.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d85302978b9d4adbadf5062dd0fb1ab"><gtr:id>7d85302978b9d4adbadf5062dd0fb1ab</gtr:id><gtr:otherNames>Van De Pette M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>58b96da9de2603.70755663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B27C49C-1FF5-4F82-BEAE-F55A181C0185</gtr:id><gtr:title>Increased dihydroceramide/ceramide ratio mediated by defective expression of degs1 impairs adipocyte differentiation and function.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10eebd282fc999b366ffec54a82ba2ef"><gtr:id>10eebd282fc999b366ffec54a82ba2ef</gtr:id><gtr:otherNames>Barbarroja N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>5454ab4f45bd66.52086977</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF2B760E-2C0B-4526-9636-99754A5BCE00</gtr:id><gtr:title>Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6013e7c1934b6d55026ed02e21ab0c8"><gtr:id>d6013e7c1934b6d55026ed02e21ab0c8</gtr:id><gtr:otherNames>Patel MN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56cdf4dd6a30c4.18057144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>419063D9-1BA6-45EC-9056-B6E75E172EA6</gtr:id><gtr:title>Stearoyl-CoA Desaturase 1 Is a Key Determinant of Membrane Lipid Composition in 3T3-L1 Adipocytes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89fbfd715cfa7a742a5e3d8de973a98c"><gtr:id>89fbfd715cfa7a742a5e3d8de973a98c</gtr:id><gtr:otherNames>Rodriguez-Cuenca S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b96da9911239.93255173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA6DC823-8F56-450C-98D2-50E1EC95E900</gtr:id><gtr:title>mTORC1 in AGRP neurons integrates exteroceptive and interoceptive food-related cues in the modulation of adaptive energy expenditure in mice.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d070040adda7596710cd3df53504e06c"><gtr:id>d070040adda7596710cd3df53504e06c</gtr:id><gtr:otherNames>Burke LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5aa4262e987b15.12948918</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0047B78-08D0-4ED8-B807-4295C2586C0E</gtr:id><gtr:title>Mitochondria are required for pro-ageing features of the senescent phenotype.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc3e216bbe4afc1611d3f8d443f0cc45"><gtr:id>bc3e216bbe4afc1611d3f8d443f0cc45</gtr:id><gtr:otherNames>Correia-Melo C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>56cdf4da8416e5.67648654</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD9D3303-056D-4A1C-9972-52B1447BCA1C</gtr:id><gtr:title>Meal rich in carbohydrate, but not protein or fat, reveals adverse immunometabolic responses associated with obesity.</gtr:title><gtr:parentPublicationTitle>Nutrition journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df813db47b72f32fdc1491b2b96ec495"><gtr:id>df813db47b72f32fdc1491b2b96ec495</gtr:id><gtr:otherNames>Parvaresh Rizi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2891</gtr:issn><gtr:outcomeId>58b96da9057fe4.80858977</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B35304E-487C-436C-9DBF-BE9332F74C15</gtr:id><gtr:title>Erratum: Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b0fe1561e92f157420919eb81c6a910"><gtr:id>5b0fe1561e92f157420919eb81c6a910</gtr:id><gtr:otherNames>Tan CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58b96da9bc2409.21300698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>351A82D7-2C1C-4EFB-9B44-9A9CBEC5F7F6</gtr:id><gtr:title>SGBS cells as a model of human adipocyte browning: A comprehensive comparative study with primary human white subcutaneous adipocytes.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84e60e527c0ad64c18ab37fb4d670877"><gtr:id>84e60e527c0ad64c18ab37fb4d670877</gtr:id><gtr:otherNames>Yeo CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa422d144b938.51242763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6B5CD3A-D0F2-47D5-A98B-3D4380AE76F4</gtr:id><gtr:title>Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f33fe815c0b14c9ca7b1106a0ea0cdef"><gtr:id>f33fe815c0b14c9ca7b1106a0ea0cdef</gtr:id><gtr:otherNames>Morton NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>58b96da892be23.81672728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A568FC8F-89EE-4625-9B5D-8D389990961C</gtr:id><gtr:title>Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/acea86a51f490daeab90416072f26605"><gtr:id>acea86a51f490daeab90416072f26605</gtr:id><gtr:otherNames>Yu E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>pm_16153_23_23841983</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1720BC6C-5A61-4F00-80C8-52088A342333</gtr:id><gtr:title>Beyond the sympathetic tone: the new brown fat activators.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7824dcd80f12b74d6eb0c88f3e1744f1"><gtr:id>7824dcd80f12b74d6eb0c88f3e1744f1</gtr:id><gtr:otherNames>Villarroya F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>pm_16153_23_23583169</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67ABE317-C9A9-4E74-968A-0F3D1023AD3A</gtr:id><gtr:title>Chronic subordination stress selectively downregulates the insulin signaling pathway in liver and skeletal muscle but not in adipose tissue of male mice.</gtr:title><gtr:parentPublicationTitle>Stress (Amsterdam, Netherlands)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8d8fda57a38e9b1a74544b26fc498bd"><gtr:id>f8d8fda57a38e9b1a74544b26fc498bd</gtr:id><gtr:otherNames>Sanghez V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1025-3890</gtr:issn><gtr:outcomeId>58b96da8b5f259.26507206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74338224-395A-4E6D-AC67-379568458791</gtr:id><gtr:title>Metabolic gene expression profile in circulating mononuclear cells reflects obesity-associated metabolic inflexibility.</gtr:title><gtr:parentPublicationTitle>Nutrition &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd1c9e5d1b95764179492b943002f2d9"><gtr:id>dd1c9e5d1b95764179492b943002f2d9</gtr:id><gtr:otherNames>Baig S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1743-7075</gtr:issn><gtr:outcomeId>58b96da960e967.60769792</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3A055B8-44B9-4954-9DBB-3623BDE6A1FA</gtr:id><gtr:title>Methods for performing lipidomics in white adipose tissue.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b6e3728c2503ea027017abe00a44c7"><gtr:id>59b6e3728c2503ea027017abe00a44c7</gtr:id><gtr:otherNames>Roberts LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>5454ab50945a63.26442030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A17A17F9-5C99-44DE-93E8-231D97A068F1</gtr:id><gtr:title>Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge.</gtr:title><gtr:parentPublicationTitle>Nutrition (Burbank, Los Angeles County, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/947476ab11b5f540ac4ddcdb10391e29"><gtr:id>947476ab11b5f540ac4ddcdb10391e29</gtr:id><gtr:otherNames>Paniagua JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0899-9007</gtr:issn><gtr:outcomeId>5454ab50eae3f4.43417567</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08E2E674-8CD0-48B9-8CD5-5AE386DAC5AC</gtr:id><gtr:title>Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21cb25ff8772b4c914687a805b1d4c64"><gtr:id>21cb25ff8772b4c914687a805b1d4c64</gtr:id><gtr:otherNames>Yew Tan C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56cdf4db555988.55544117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>787A1CBE-1A1E-4BD3-8DF8-74E8615EBB92</gtr:id><gtr:title>Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5a69ea6f4a1d6fc95c62d23826bd9ab"><gtr:id>b5a69ea6f4a1d6fc95c62d23826bd9ab</gtr:id><gtr:otherNames>Mart?nez-S?nchez N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>5aa422d1029668.86108413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14650602-3DDD-48EA-91C2-3803AA77772E</gtr:id><gtr:title>Ribosomal S6K1 in POMC and AgRP Neurons Regulates Glucose Homeostasis but Not Feeding Behavior in Mice.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84d3a573c1453e15a13c9f49a575fa11"><gtr:id>84d3a573c1453e15a13c9f49a575fa11</gtr:id><gtr:otherNames>Smith MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56cdf4dd3a7ff7.29056381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E235D138-61AB-46E1-BC41-E440EC149801</gtr:id><gtr:title>Lipopolysaccharide binding protein is an adipokine involved in the resilience of the mouse adipocyte to inflammation.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c76c446e6a2d372e762aff1c0ce3437"><gtr:id>9c76c446e6a2d372e762aff1c0ce3437</gtr:id><gtr:otherNames>Moreno-Navarrete JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>56cdf4dc26d7c3.92312199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E9BD9C7-109C-4384-9D12-BF9EB183A44E</gtr:id><gtr:title>Pharmacological strategies for targeting BAT thermogenesis.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4812c617c0423911393576c4924e270b"><gtr:id>4812c617c0423911393576c4924e270b</gtr:id><gtr:otherNames>Whittle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn><gtr:outcomeId>pm_16153_23_23648356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA17266B-1DC3-4E4E-ACC7-4BB8147367AE</gtr:id><gtr:title>No metabolic effects of mustard allyl-isothiocyanate compared with placebo in men.</gtr:title><gtr:parentPublicationTitle>The American journal of clinical nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f3b85100cc68f927a987094bb780b7d"><gtr:id>1f3b85100cc68f927a987094bb780b7d</gtr:id><gtr:otherNames>Langeveld M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9165</gtr:issn><gtr:outcomeId>5aa422cfee05d2.95025876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99B81BCB-31C1-4ADF-B525-864F7CBBD7F2</gtr:id><gtr:title>Understanding disease mechanisms with models of signaling pathway activities.</gtr:title><gtr:parentPublicationTitle>BMC systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ba2e363d87b2d75eaa0ff3daa3b2bcf"><gtr:id>1ba2e363d87b2d75eaa0ff3daa3b2bcf</gtr:id><gtr:otherNames>Sebastian-Leon P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1752-0509</gtr:issn><gtr:outcomeId>5454ab4f98d4d8.60678801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DCF54ED-4E11-4755-AFA7-B132F7712F5F</gtr:id><gtr:title>Sphingolipids and glycerophospholipids - The &amp;quot;ying and yang&amp;quot; of lipotoxicity in metabolic diseases.</gtr:title><gtr:parentPublicationTitle>Progress in lipid research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89fbfd715cfa7a742a5e3d8de973a98c"><gtr:id>89fbfd715cfa7a742a5e3d8de973a98c</gtr:id><gtr:otherNames>Rodriguez-Cuenca S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0163-7827</gtr:issn><gtr:outcomeId>5a2fcd2781d208.79983410</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC5A7A06-3333-4F8D-B031-AAA45FBEE550</gtr:id><gtr:title>Phenyl-?-valerolactones, flavan-3-ol colonic metabolites, protect brown adipocytes from oxidative stress without affecting their differentiation or function.</gtr:title><gtr:parentPublicationTitle>Molecular nutrition &amp; food research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da7972d12b05162651eb0d2672d0701c"><gtr:id>da7972d12b05162651eb0d2672d0701c</gtr:id><gtr:otherNames>Mele L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1613-4125</gtr:issn><gtr:outcomeId>5aa422d19d4158.83565243</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BAFAAD1-EE83-44E9-BF90-8E930A33862B</gtr:id><gtr:title>Adipose Tissue Function and Expandability as Determinants of Lipotoxicity and the Metabolic Syndrome.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3098d46384b300a0dd4b590e33f76cd"><gtr:id>f3098d46384b300a0dd4b590e33f76cd</gtr:id><gtr:otherNames>Carobbio S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>5aa422d1be8b98.94678147</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4E5D612-F5DD-4754-9AFB-0BCEDA0CB5F4</gtr:id><gtr:title>Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85cfe6a2cb489fb34b58849de6263fd1"><gtr:id>85cfe6a2cb489fb34b58849de6263fd1</gtr:id><gtr:otherNames>Whittle AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56cdf4dbe8afe8.92410160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C07AF7E-C139-439B-937D-C802B603D5CA</gtr:id><gtr:title>Assessment of plasma acylcarnitines before and after weight loss in obese subjects.</gtr:title><gtr:parentPublicationTitle>Archives of biochemistry and biophysics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df8f26177b5e893b616c20790e446002"><gtr:id>df8f26177b5e893b616c20790e446002</gtr:id><gtr:otherNames>Schooneman MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-9861</gtr:issn><gtr:outcomeId>58b96da83cf545.54452190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE21BFD6-17DD-4CB4-B37E-1B01F673FE5D</gtr:id><gtr:title>Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/868944d48eed9c849dce745b475cdcc6"><gtr:id>868944d48eed9c849dce745b475cdcc6</gtr:id><gtr:otherNames>Lee EY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56cdf4db8424c3.33312852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37A94835-33F6-46ED-B99D-0CF88720BE18</gtr:id><gtr:title>Human Adipocytes Induce Inflammation and Atrophy in Muscle Cells During Obesity.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2f6fa35b5d82a323e0c15bcb6bdef6d"><gtr:id>a2f6fa35b5d82a323e0c15bcb6bdef6d</gtr:id><gtr:otherNames>Pellegrinelli V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>56cdf4dc516829.71235476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57DFBC3B-43B3-41D9-B4A0-214439EDCD28</gtr:id><gtr:title>Regulation of mitochondrial morphology and function by stearoylation of TFR1.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79ebcc3b3a811bc866b680f632d96c20"><gtr:id>79ebcc3b3a811bc866b680f632d96c20</gtr:id><gtr:otherNames>Senyilmaz D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56cdf4dc9af208.95616123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA9BC5CE-16BF-47F8-B408-06930B513821</gtr:id><gtr:title>Stress-induced activation of brown adipose tissue prevents obesity in conditions of low adaptive thermogenesis.</gtr:title><gtr:parentPublicationTitle>Molecular metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3201778a0bdec2442d6b503f1aabf092"><gtr:id>3201778a0bdec2442d6b503f1aabf092</gtr:id><gtr:otherNames>Razzoli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2212-8778</gtr:issn><gtr:outcomeId>56cdf4dae41b66.10232943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>457B3684-875C-4B98-8617-91673E3F5760</gtr:id><gtr:title>DLK1/PREF1 regulates nutrient metabolism and protects from steatosis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3ddd6d250134b9506e71148f32e6cb2"><gtr:id>d3ddd6d250134b9506e71148f32e6cb2</gtr:id><gtr:otherNames>Charalambous M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5454ab4f6fae89.69627253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>420F0803-204F-420C-8B8A-1A6FBDD9C127</gtr:id><gtr:title>Mild cold effects on hunger, food intake, satiety and skin temperature in humans.</gtr:title><gtr:parentPublicationTitle>Endocrine connections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f3b85100cc68f927a987094bb780b7d"><gtr:id>1f3b85100cc68f927a987094bb780b7d</gtr:id><gtr:otherNames>Langeveld M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2049-3614</gtr:issn><gtr:outcomeId>56cdf4dab7b274.21323396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>647DFA2E-9C15-4416-97DB-3E9850A3EE93</gtr:id><gtr:title>Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b0fe1561e92f157420919eb81c6a910"><gtr:id>5b0fe1561e92f157420919eb81c6a910</gtr:id><gtr:otherNames>Tan CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56cdf4db246768.87965613</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9575773-8184-4F03-8B33-9CA42EE6DF7F</gtr:id><gtr:title>Identification of novel type 2 diabetes candidate genes involved in the crosstalk between the mitochondrial and the insulin signaling systems.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f7253b5931c04f673d9c0039f28dc78"><gtr:id>1f7253b5931c04f673d9c0039f28dc78</gtr:id><gtr:otherNames>Mercader JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_16153_23_23236286</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FBA3C85-08B4-4128-964F-E07FE0C1B70D</gtr:id><gtr:title>Protein CoAlation: a redox-regulated protein modification by coenzyme A in mammalian cells.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/017409e614c78b536c7c65683fedc43a"><gtr:id>017409e614c78b536c7c65683fedc43a</gtr:id><gtr:otherNames>Tsuchiya Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5aa422d1241983.61731612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>591B7CD6-9CB8-4202-B100-0C8511BF634B</gtr:id><gtr:title>Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD.</gtr:title><gtr:parentPublicationTitle>Seminars in liver disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fe0043d25a0888851cac9f3a9f58eb4"><gtr:id>7fe0043d25a0888851cac9f3a9f58eb4</gtr:id><gtr:otherNames>Vacca M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0272-8087</gtr:issn><gtr:outcomeId>56cdf4dccdbbc4.86135603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F9100BA-0A41-4677-B934-3F102677F0DF</gtr:id><gtr:title>Hypophagia and metabolic adaptations in mice with defective ATGL-mediated lipolysis cause resistance to HFD-induced obesity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a83d91cb92130960ceb8bd8bd2f5d62"><gtr:id>1a83d91cb92130960ceb8bd8bd2f5d62</gtr:id><gtr:otherNames>Schreiber R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56cdf4dbb6ed89.00910544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0FDD791-A9FA-4512-B619-EB00022AEFC4</gtr:id><gtr:title>Adipose tissue expandability, lipotoxicity and the metabolic syndrome.</gtr:title><gtr:parentPublicationTitle>Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef7a90ce74f1aa7ffc80786b5a155570"><gtr:id>ef7a90ce74f1aa7ffc80786b5a155570</gtr:id><gtr:otherNames>Vidal-Puig A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1575-0922</gtr:issn><gtr:outcomeId>5454ab50ba6bc3.26245336</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B42BC451-A216-4EAC-ACA4-4824116D9446</gtr:id><gtr:title>Regulation of glucose homoeostasis by brown adipose tissue.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f78416e5a69118d3de1d9d6de0470863"><gtr:id>f78416e5a69118d3de1d9d6de0470863</gtr:id><gtr:otherNames>Peirce V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>5454ab506dcea5.03098009</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76FE07E8-D4BF-4E55-8949-A4E90CDB2938</gtr:id><gtr:title>Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8face52ad7d0211d931dd00159b1afe3"><gtr:id>8face52ad7d0211d931dd00159b1afe3</gtr:id><gtr:otherNames>Hall Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>58b96da93d0964.82121958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E58D3D0D-15AA-44CA-A7E5-7254BB2764E2</gtr:id><gtr:title>Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2f6fa35b5d82a323e0c15bcb6bdef6d"><gtr:id>a2f6fa35b5d82a323e0c15bcb6bdef6d</gtr:id><gtr:otherNames>Pellegrinelli V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>58b96da86913f3.12801721</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25118F7F-2A14-4179-A4C7-578B116D97E1</gtr:id><gtr:title>Assessment of brown adipose tissue function.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e137cbde914442352a009c77419799ba"><gtr:id>e137cbde914442352a009c77419799ba</gtr:id><gtr:otherNames>Virtue S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn><gtr:outcomeId>pm_16153_23_23760815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F93A2606-7936-46C0-B38F-695A932879A0</gtr:id><gtr:title>Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89fbfd715cfa7a742a5e3d8de973a98c"><gtr:id>89fbfd715cfa7a742a5e3d8de973a98c</gtr:id><gtr:otherNames>Rodriguez-Cuenca S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>5454ab4fc30ed4.97369621</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B93903A2-BE33-474A-8F75-35529FC4FC70</gtr:id><gtr:title>The different shades of fat.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f78416e5a69118d3de1d9d6de0470863"><gtr:id>f78416e5a69118d3de1d9d6de0470863</gtr:id><gtr:otherNames>Peirce V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5454ab501bde29.70937077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BD6352D-6348-49B4-B275-342235F883CB</gtr:id><gtr:title>Adipogenesis: new insights into brown adipose tissue differentiation.</gtr:title><gtr:parentPublicationTitle>Journal of molecular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3098d46384b300a0dd4b590e33f76cd"><gtr:id>f3098d46384b300a0dd4b590e33f76cd</gtr:id><gtr:otherNames>Carobbio S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0952-5041</gtr:issn><gtr:outcomeId>pm_16153_23_24041933</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12012/2</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>